{"gene":"BCL11B","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2003,"finding":"Bcl11b is required for V(beta) to D(beta) recombination and Tcrb mRNA expression in thymocytes; Bcl11b-deficient mice show a developmental block at the CD4-CD8 double-negative stage with absent pre-TCR complex on the cell surface and profound apoptosis, establishing Bcl11b as a key regulator of both differentiation and survival during thymocyte development.","method":"Bcl11b knockout mouse model; flow cytometry; PCR for Tcrb expression","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO mouse with specific developmental phenotype and molecular mechanism (absent Tcrb mRNA, failed V(D)J recombination), replicated by multiple subsequent labs","pmids":["12717433"],"is_preprint":false},{"year":2007,"finding":"CTIP2 (BCL11B) recruits histone deacetylases HDAC1 and HDAC2 to promote local histone H3 deacetylation at the HIV-1 promoter, and associates with histone methyltransferase SUV39H1 to increase local H3K9 methylation, enabling HP1 protein recruitment and heterochromatin formation to silence HIV-1 transcription in microglial cells.","method":"Co-immunoprecipitation; chromatin immunoprecipitation (ChIP); reporter assays; confocal microscopy in microglial cells","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP and ChIP with multiple orthogonal methods; independently replicated concept in subsequent papers","pmids":["17245431"],"is_preprint":false},{"year":2003,"finding":"CTIP2 colocalizes and physically associates with heterochromatin protein HP1alpha, and forms a three-protein complex with HIV-1 Tat via two distinct CTIP2 domains (residues 145-434 for Tat binding, 717-813 for HP1 binding), recruiting Tat into inactive chromatin regions and inhibiting Tat-mediated transactivation of HIV-1 in microglial cells.","method":"Co-immunoprecipitation; confocal microscopy; deletion mutant analysis; HIV-1 replication assays","journal":"Journal of virology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, domain mapping with deletion mutants, and functional HIV-1 replication readout in single study","pmids":["12692243"],"is_preprint":false},{"year":2006,"finding":"CTIP2 associates with the NuRD complex through direct interaction with RbAp46 and RbAp48 subunits, confers histone deacetylase activity to CTIP2 complexes, and co-occupies the p57KIP2 promoter with NuRD components to repress p57KIP2 transcription in neuroblastoma cells.","method":"Co-immunoprecipitation; chromatin immunoprecipitation (ChIP); HDAC activity assays; reporter assays in SK-N-MC cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct protein interaction mapped (RbAp46/48), ChIP at endogenous target gene, HDAC activity assay; multiple orthogonal methods in single study","pmids":["16950772"],"is_preprint":false},{"year":2007,"finding":"BCL11B is required for positive selection of both CD4 and CD8 T cell lineages in double-positive thymocytes; BCL11B-deficient DP thymocytes display impaired proximal TCR signaling, attenuated ERK phosphorylation and calcium flux, and increased spontaneous apoptosis associated with elevated cleaved caspase-3 and altered pro-apoptotic/pro-survival factor balance.","method":"Conditional BCL11B knockout mice; flow cytometry; calcium flux assays; ERK phosphorylation assays; TCR transgene rescue experiments","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal functional assays in KO model with defined cellular and molecular phenotypes; TCR transgene rescue experiment provides epistasis","pmids":["17998389"],"is_preprint":false},{"year":2008,"finding":"Ctip2 is a major downstream effector of Fezf2 in specifying subcortical projection neuron fate in the cerebral cortex; ectopic Ctip2 expression redirects callosal projection neurons to project subcortically, and Ctip2 can rescue the axonal phenotype of Fezf2 mutants, placing Ctip2 genetically downstream of Fezf2 in this pathway.","method":"Fezf2 knockout mice; in utero electroporation; axonal tracing; epistasis analysis with double mutants","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis via double mutant and rescue, axonal tracing; replicated by subsequent independent studies","pmids":["18678899"],"is_preprint":false},{"year":2008,"finding":"Ctip2 is required for differentiation of striatal medium spiny neurons (MSN); in its absence, MSN markers including DARPP-32, FOXP1, Chrm4, and Plexin-D1 are dramatically reduced, MSN fail to aggregate into patches, and dopaminergic innervation is abnormal, establishing Ctip2 as a critical regulator of MSN differentiation and striatal architecture.","method":"Ctip2 knockout mice; immunohistochemistry; gene expression analysis; histological analysis of striatal organization","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with specific molecular and cellular phenotype; multiple downstream target genes identified; replicated concept in subsequent work","pmids":["18199763"],"is_preprint":false},{"year":2009,"finding":"CTIP2 silences the p21(WAF1) gene promoter by recruiting histone deacetylases and cooperating with SUV39H1 histone methyltransferase; CTIP2 and SUV39H1 co-occupy the silenced p21 promoter and cooperatively inhibit p21 transcription through histone H3K9 trimethylation, and CTIP2 abolishes Vpr-mediated stimulation of p21.","method":"ChIP; pharmacological inhibition with chaetocin (SUV39H1 inhibitor); reporter assays; siRNA knockdown; cell cycle analysis","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP at endogenous promoter, pharmacological inhibitor rescue, and functional cell cycle readout; multiple orthogonal methods","pmids":["19581932"],"is_preprint":false},{"year":2011,"finding":"LSD1 histone demethylase cooperates with CTIP2 to repress HIV-1 transcription in a synergistic manner; LSD1 recruitment to the HIV-1 proximal promoter is associated with both H3K4me3 and H3K9me3 epigenetic marks.","method":"ChIP; siRNA knockdown of LSD1; reporter assays; viral expression assays in microglial cells","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — ChIP and siRNA in single study; synergy shown but direct interaction of CTIP2-LSD1 not fully established by Co-IP","pmids":["22067449"],"is_preprint":false},{"year":2012,"finding":"Bcl11b/Ctip2 plays a dual role in hippocampal neurogenesis: it controls feedback regulation of the progenitor cell compartment and regulates granule cell differentiation. Desmoplakin is identified as a direct transcriptional target of Bcl11b, and re-expression of Desmoplakin in Bcl11b mutants rescues impaired neurogenesis, placing Bcl11b upstream of Desmoplakin in hippocampal development.","method":"Forebrain-specific Bcl11b knockout mice; ChIP for direct target identification; Desmoplakin rescue experiment; behavioral testing (spatial learning)","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct target gene identified by ChIP, genetic rescue experiment establishing epistasis, behavioral phenotype readout","pmids":["22588081"],"is_preprint":false},{"year":2013,"finding":"CTIP2 is a negative regulator of P-TEFb activity; CTIP2 copurifies and interacts with an inactive P-TEFb complex containing 7SK snRNA and HEXIM1, associating directly with HEXIM1 and via the loop 2 of 7SK snRNA with P-TEFb, and significantly represses Cdk9 kinase activity. In hypertrophic cardiomyopathic mouse hearts, the inactive P-TEFb/CTIP2 complex associates with the MYH7 gene promoter to repress its activity.","method":"Co-purification; Co-immunoprecipitation; Cdk9 kinase activity assay; ChIP at MYH7 promoter; RNA-seq; siRNA knockdown","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro kinase assay + Co-IP of endogenous complex + ChIP at target promoter + disease model; multiple orthogonal methods","pmids":["23852730"],"is_preprint":false},{"year":2013,"finding":"BCL11B acts as a transcriptional repressor in Ewing sarcoma and contributes to the EWS/FLI repressed gene signature; its repressive activity is mediated through the NuRD co-repressor complex. Re-expression of SPRY1, a repressed BCL11B target, limits transformation in Ewing sarcoma cells.","method":"siRNA knockdown; gene expression profiling; reporter assays; Co-immunoprecipitation for NuRD complex association","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for NuRD association, functional rescue with SPRY1 re-expression, KD with transformation phenotype; single lab","pmids":["23527175"],"is_preprint":false},{"year":2014,"finding":"HMGA1 recruits the CTIP2-repressed inactive P-TEFb/7SK snRNP complex to cellular gene promoters and the HIV-1 promoter; HMGA1 knockdown reduces ChIP signals for CTIP2, 7SK, and P-TEFb at target promoters, revealing HMGA1 as the recruiting mechanism for the inactive P-TEFb complex.","method":"ChIP; siRNA knockdown of HMGA1 and CTIP2; reporter assays for HIV-1 and cellular promoters","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and combinatorial knockdown showing recruitment dependency; single lab, two orthogonal methods","pmids":["24623795"],"is_preprint":false},{"year":2014,"finding":"Unc5C expression is under direct negative regulation by Ctip2 in cortical neurons; Ctip2 directly represses Unc5C, and the Netrin1-Unc5C interaction downstream of Ctip2 controls corticofugal axon projections.","method":"Conditional knockout mice; ChIP (direct regulation); axonal tracing; epistasis analysis","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for direct target, genetic epistasis with Unc5C and Ctip2 mutants; single lab","pmids":["24739528"],"is_preprint":false},{"year":2015,"finding":"Bcl11b acts directly upstream of Gfi1 to maintain its expression in mature ILC2s, and independently represses expression of the ILC3 transcription factor Ahr; Bcl11b-deficient ILC2s downregulate Gata3 and downstream IL-33 receptor, and upregulate Rorc and ILC3 genes, demonstrating a dual role in maintaining ILC2 identity and suppressing ILC3 programming.","method":"Conditional Bcl11b knockout mice; gene expression analysis; flow cytometry; functional cytokine production assays; ChIP for direct Ahr repression","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with defined target genes (Gfi1, Ahr), ChIP for direct binding, functional cytokine output readout; replicated in parallel independent study (PMID 25964370)","pmids":["26231117"],"is_preprint":false},{"year":2015,"finding":"Bcl11b is wholly required for ILC2 development; in vivo deletion of Bcl11b abolishes ILC2 generation with concomitant expansion of RORγt+ ILC3 population, suggesting Bcl11b negatively regulates the ILC3 lineage.","method":"Bcl11b reporter mice; conditional tamoxifen-induced deletion; fetal liver chimera reconstitution; flow cytometry; Nippostrongylus brasiliensis infection model","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent in vivo deletion strategies (inducible and chimera); functional infection model; replicated by Califano et al. simultaneously","pmids":["25964370"],"is_preprint":false},{"year":2016,"finding":"Bcl11b expression is activated through three distinct asynchronous mechanisms during T cell commitment: an early locus 'poising' function dependent on TCF-1 and GATA-3, a stochastic-permissivity function dependent on Notch signaling, and an amplitude-control function dependent on Runx1; these inputs act in a stage-specific manner to activate Bcl11b.","method":"Single-cell live imaging with Bcl11b knock-in fluorescent reporter mice; genetic perturbations of TCF-1, GATA-3, Notch, and Runx1; clonal analysis","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — single-cell resolution with knock-in reporter, multiple genetic perturbations establishing mechanistic hierarchy; multiple orthogonal approaches in single rigorous study","pmids":["27376470"],"is_preprint":false},{"year":2016,"finding":"Protein kinase C (PKC)-mediated phosphorylation of BCL11B at Serine 2 negatively regulates its interaction with NuRD complexes by dampening interaction with MTA1/MTA3 and RbAp46; upon T cell activation, phospho-Ser2 BCL11B still binds IL-2 and Id2 promoters but recruits P300 instead of MTA1 to activate transcription, defining a PTM-driven repressor-to-activator switch.","method":"Co-immunoprecipitation of endogenous MTA1/MTA3; phospho-specific antibodies; ChIP at IL-2 and Id2 promoters; in vivo activation of primary human CD4+ T cells","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — endogenous Co-IP with mapped PTM site, ChIP showing cofactor switch at target promoters, validated in primary human cells","pmids":["27161321"],"is_preprint":false},{"year":2016,"finding":"Bcl11b promotes mammary epithelial stem cell quiescence; gain- and loss-of-function studies show that Bcl11b induces cells to enter G0, and loss of Bcl11b leads to Cdkn2a-dependent exhaustion of ductal epithelium and loss of regenerative capacity.","method":"Conditional knockout mice; transplantation assays; gain-of-function overexpression; cell cycle analysis (G0 determination); genetic interaction with Cdkn2a","journal":"Cell stem cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO and OE with cell cycle readout, genetic epistasis with Cdkn2a; single lab","pmids":["28041896"],"is_preprint":false},{"year":2018,"finding":"Bcl11b recruits distinct cofactors to selective target sites in pro-T cells; proteomics identified multiple Bcl11b-associated cofactors, Runx1 collaborates most frequently for both activation and repression, and Bcl11b directly represses Id2 and Zbtb16, which in turn control alternative innate lymphoid and NK/NKT cell programs.","method":"Proteomics (affinity purification-MS); ChIP-seq; stage-specific in vivo and in vitro deletions; RNA-seq; cofactor deletion epistasis","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — AP-MS for cofactor identification, ChIP-seq for genome-wide binding, genetic deletion of individual cofactors; multiple orthogonal methods in single rigorous study","pmids":["30374131"],"is_preprint":false},{"year":2018,"finding":"Bcl11b binds GATA3 through protein-protein interaction, and they co-localize at Th2 cis-regulatory elements. The GATA3/Bcl11b complex limits Th2 gene expression (IL-4, IL-5, IL-13), and Bcl11b upregulation of these cytokines in Bcl11b-deficient cells is completely GATA3-dependent.","method":"Co-immunoprecipitation; ChIP-seq; RNA-seq; Bcl11b conditional KO in Th2 cells; GATA3-dependence genetic rescue","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct protein interaction (Co-IP), genome-wide co-binding (ChIP-seq), and genetic GATA3 epistasis; multiple orthogonal methods","pmids":["29514917"],"is_preprint":false},{"year":2018,"finding":"BCL11B homodimerizes via its N-terminal CCHC zinc finger motif; this CCHC ZF is necessary and sufficient for dimer formation, and mutation of the CCHC ZF abolishes BCL11B transcription-regulatory activity, its ability to induce cell cycle arrest, and its protection against DNA-damage-driven apoptosis.","method":"FACS-FRET assay; affinity purification followed by mass spectrometry; deletion/point mutagenesis; cell cycle and apoptosis assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — domain mapped by mutagenesis + FRET + AP-MS; functional consequences of dimerization disruption assessed; multiple orthogonal methods in single study","pmids":["29203643"],"is_preprint":false},{"year":2018,"finding":"Bcl11b is required for maintaining chromatin accessibility at Th2-cytokine promoters and locus-control regions, binds the Il4 HS IV silencer to reduce its accessibility, binds Gata3-intronic and downstream non-coding sites to sustain Gata3 expression, and binds upstream enhancers at the Runx3 locus to deactivate them, thereby restricting Runx3 expression in Th2 cells.","method":"ChIP-seq; ATAC-seq; conditional Bcl11b KO in mature T cells; helminth infection and allergic asthma models","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq and ATAC-seq providing mechanistic chromatin-level evidence; in vivo disease models; single lab with multiple orthogonal methods","pmids":["29700302"],"is_preprint":false},{"year":2019,"finding":"HIV-1 Vpr mediates proteasomal degradation of CTIP2 in microglial cells and CD4+ T cells via association with the Cul4A-DDB1-DCAF1 ubiquitin ligase complex; this Vpr-dependent depletion of CTIP2 at the latent HIV-1 promoter counteracts CTIP2-mediated viral gene silencing and reactivates HIV-1 expression.","method":"Co-immunoprecipitation with Cul4A-DDB1-DCAF1 complex; proteasome inhibitor rescue; ChIP at HIV-1 promoter; microglial HIV-1 latency model","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP defining the ubiquitin ligase complex, proteasome inhibitor rescue, and ChIP; single lab","pmids":["31511615"],"is_preprint":false},{"year":2020,"finding":"Bcl11b binding to genomic regions shows distinct cell-type-specific motif preferences and occupies functionally different sites in pro-T cells versus ILC2s, controlling totally different sets of target genes. In pro-T cells, Bcl11b represses Id2 preventing innate fates; in ILC2s, Bcl11b co-expresses with Id2 and does not repress it. Additionally, Bcl11b bears cell-type-specific post-translational modifications and organizes different cell-type-specific protein complexes.","method":"ChIP-seq comparing pro-T cells and ILC2s; proteomics; conditional cell-type-specific KO; gene expression analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — comparative ChIP-seq across cell types, AP-MS proteomics for complex composition, conditional KO; multiple orthogonal methods","pmids":["31653691"],"is_preprint":false},{"year":2012,"finding":"Ctip2 directly and positively regulates EGFR transcription in proliferating keratinocytes and Notch1 transcription in differentiating keratinocytes, integrating proliferation/differentiation switching; EGFR activation downregulates Ctip2 at the transcript level, while high calcium signaling triggers SUMOylation, ubiquitination, and proteasomal degradation of Ctip2 protein.","method":"ChIP at EGFR and Notch1 promoters; reporter assays; calcium treatment; SUMOylation/ubiquitination assays; proteasome inhibitor experiments","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP at endogenous promoters plus PTM characterization; single lab with multiple methods","pmids":["23015591"],"is_preprint":false},{"year":2015,"finding":"Bcl11b regulates Wnt/β-catenin target gene expression; introduction of BCL11B in human cell lines downregulated transcription of β-catenin target genes, and Bcl11b attenuation in intestinal Lgr5+ crypt base columnar cells increased expression of β-catenin targets c-Myc and cyclin D1, linking BCL11B to intestinal tumorigenesis suppression.","method":"BCL11B overexpression in human cell lines; luciferase reporter assays for β-catenin targets; Lgr5-specific conditional KO mice; Apc(min/+) tumor model","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay and conditional KO with pathway-specific readout; single lab","pmids":["25827435"],"is_preprint":false},{"year":2016,"finding":"HIC1 physically interacts with both Bcl11b/CTIP2 and HMGA1 to co-regulate HIV-1 gene expression; HIC1 represses Tat-dependent HIV-1 transcription, this repression is linked to HIC1 K314 acetylation status and SIRT1 deacetylase activity, and HIC1 repression of Tat function occurs in a TAR-dependent manner.","method":"Co-immunoprecipitation; reporter assays; siRNA knockdown; acetylation assays; SIRT1 inhibitor treatment","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for protein interactions, reporter assays, PTM (acetylation) dependency; single lab","pmids":["27725726"],"is_preprint":false},{"year":2016,"finding":"Bcl11b is required for BCL11B-dependent repression of Thpok prior to the pre-selection stage of thymocyte development; this initial Thpok repression is independent of the known Thpok silencer and requires the last zinc-finger motif of Bcl11b, which is dispensable for T-lineage commitment, thus mechanistically separating priming of lineage-specifying genes from commitment.","method":"Conditional Bcl11b KO mice; zinc-finger domain deletion mutants; gene expression analysis of Thpok and Runx3; lineage scrambling analysis","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain-specific mutant analysis separating functions, KO with specific molecular readout; single lab","pmids":["28951542"],"is_preprint":false},{"year":2019,"finding":"Bcl11b controls odorant receptor class choice in olfactory sensory neurons; loss of Bcl11b causes neurons to adopt class I OR fate by default, while gain-of-function shows Bcl11b dictates class II OR choice by suppressing the activity of the J-element, a class I-OR enhancer, revealing a binary transcriptional switch mechanism.","method":"Conditional Bcl11b KO and gain-of-function mice; in situ hybridization for OR class expression; behavioral olfaction assays","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — both LOF and GOF genetic experiments establishing regulatory mechanism; single lab","pmids":["31396576"],"is_preprint":false},{"year":2019,"finding":"Bcl11b directly binds genomic regulatory regions of Treg program genes, overlapping with Foxp3 binding, and controls their chromatin accessibility; Bcl11b-deficient Treg cells show decreased expression of essential Treg program genes and gain myeloid and NK cell programs, demonstrating Bcl11b restrains innate lineage programs in Treg cells.","method":"Treg-specific conditional KO mice; ChIP-seq; ATAC-seq; gene expression analysis; autoimmunity phenotypic assay","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq and ATAC-seq in KO Treg cells, comparison with Foxp3 binding, fatal autoimmunity phenotype; multiple orthogonal methods","pmids":["31457080"],"is_preprint":false},{"year":2021,"finding":"BCL11B regulates NK cell differentiation; Bcl11b represses RUNX2 in canonical NK cells and ZBTB16 in adaptive NK cells; ectopic Bcl11b expression drives NK cell differentiation, and Bcl11b is required for adaptive NK cell responses in a murine cytomegalovirus model.","method":"Transcriptomics and epigenomics of seven human NK cell populations; ectopic Bcl11b expression; BCL11B-mutated patient analysis; MCMV infection model","journal":"Science immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ectopic expression, patient mutation validation, and infection model; multi-method single study","pmids":["33712472"],"is_preprint":false},{"year":2023,"finding":"BCL11B and the NuRD complex physically associate and cooperatively repress NK-cell fate in T cells; deletion of NuRD subunits (MTA2, MBD2, CHD4) or BCL11B reprograms T cells into NK-like cells (ITNKs) that upregulate OPA1, exhibit elongated mitochondria with augmented OXPHOS, and elevated acetyl-CoA that drives H3K27 acetylation at specific targets.","method":"Co-immunoprecipitation of BCL11B with NuRD; genetic deletion of NuRD subunits and BCL11B in human T cells; metabolic profiling (OXPHOS); ChIP for H3K27ac; functional antitumor assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP of endogenous complex, multiple component deletions, metabolic mechanistic link to epigenetics via acetyl-CoA/H3K27ac; multiple orthogonal methods","pmids":["37737560"],"is_preprint":false},{"year":2024,"finding":"Bcl11b directly regulates C1ql2, a synaptic organizer that controls synaptic vesicle recruitment and LTP at mossy fiber-CA3 synapses; C1ql2 exerts its function through direct interaction with the specific splice variant Nrxn3(25b+), and interruption of C1ql2-Nrxn3(25b+) interaction or deletion of Nrxn3 in dentate gyrus granule neurons recapitulates Bcl11b and C1ql2 mutant synaptic phenotypes.","method":"ChIP for direct Bcl11b target; conditional KO mice; electrophysiology (LTP at mossy fiber-CA3); Co-IP of C1ql2-Nrxn3(25b+); non-binding C1ql2 mutant rescue; synaptic vesicle analysis","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct target identified by ChIP, interaction mapped by Co-IP with non-binding mutant, in vivo LTP assays, genetic rescue; multiple orthogonal methods in single rigorous study","pmids":["38358390"],"is_preprint":false},{"year":2024,"finding":"BCL11B succeeds PU.1 in a 'relay' mechanism to maintain mSWI/SNF chromatin remodeling complex occupancy together with RUNX1 at T effector loci after PU.1 silencing during lineage commitment, thereby poising the T cell effector chromatin landscape before TCR expression.","method":"ATAC-seq; ChIP-seq for BCL11B, RUNX1, PU.1, mSWI/SNF components; conditional KO at defined developmental stages; chromatin accessibility profiling","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq and ATAC-seq defining sequential occupancy mechanism, conditional KO validation; single rigorous study with multiple orthogonal genomic methods","pmids":["38632339"],"is_preprint":false},{"year":2019,"finding":"CTIP2 governs PKA signaling in human medium spiny neurons; transcriptomic analysis of CTIP2-deficient MSNs identifies CTIP2 target genes at the heart of cAMP-Ca2+ signal integration, and CTIP2 deficiency causes substantial reduction in phosphorylation of DARPP32 and GLUR1, two PKA targets. This CTIP2-dependent dysregulation is shared by Huntington's disease hPSC-derived MSNs and HD mouse model striatal tissues.","method":"Transcriptomics of CTIP2-deficient human iPSC-derived MSNs; phosphorylation analysis of DARPP32 and GLUR1; HD mouse model validation","journal":"Stem cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO with specific molecular readout (phosphorylation), validated in disease model; single lab with two orthogonal approaches","pmids":["31447328"],"is_preprint":false},{"year":2012,"finding":"BCL11B regulates FGF, TGFβ superfamily, Sprouty, and Sonic hedgehog pathway gene networks to control epithelial proliferation and developmental asymmetry of the mouse incisor; BCL11B is necessary for proliferation of the labial epithelium and suppresses epithelial proliferation on the lingual side, establishing bidirectional context-dependent transcriptional control.","method":"Bcl11b conditional KO mice (incisor-specific); ChIP; gene expression analysis of FGF/TGFβ/Shh target genes","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for direct target binding, KO with specific molecular network characterization; single lab","pmids":["22629441"],"is_preprint":false},{"year":2015,"finding":"Bcl11b-deficient craniofacial skeleton shows increased proliferation of osteoprogenitors, premature osteoblast differentiation, and enhanced skull mineralization leading to craniosynostosis; ectopic expression of Fgfr2c and Runx2 is detected in affected sutures of Bcl11b-/- mice, suggesting BCL11B normally represses Fgfr2c in sutural mesenchyme to prevent the RUNX2-dependent osteogenic program.","method":"Bcl11b knockout mice; histology; immunohistochemistry for FGFR2c and RUNX2; gene expression analysis","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — KO with specific molecular phenotype but direct regulation of Fgfr2c by BCL11B not confirmed by ChIP; single lab","pmids":["26453795"],"is_preprint":false},{"year":2016,"finding":"BCL11B regulates adipogenesis by stimulating C/EBPβ transcriptional activity and suppressing the Wnt/β-catenin signaling pathway; BCL11B expression transiently increases during adipogenesis, BCL11B knockdown reduces adipogenic capacity in 3T3-L1 cells and MEFs, and BCL11B-/- MEFs show failure to suppress Wnt/β-catenin target genes during differentiation.","method":"BCL11B knockout MEFs; 3T3-L1 knockdown; luciferase reporter assays for C/EBPβ activity and β-catenin targets; gene expression analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO MEFs and knockdown cells with reporter assays defining pathway; single lab","pmids":["27586877"],"is_preprint":false},{"year":2012,"finding":"Ctip2 controls epidermal lipid metabolism; Ctip2-/- mice display altered ceramide and sphingomyelin composition, and Ctip2 is recruited to the promoter regions of genes involved in skin sphingolipid biosynthesis, suggesting direct transcriptional regulation of these genes.","method":"Ctip2 knockout mice; targeted lipidomics by mass spectrometry; ChIP at sphingolipid gene promoters","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for direct target genes combined with metabolomic phenotype in KO; single lab","pmids":["23096701"],"is_preprint":false},{"year":2023,"finding":"Bcl11b sustains the multipotent/multifunctional transcriptional program of intestinal-resident memory CD8+ T cells by maintaining chromatin accessibility and activating histone marks at TCF7 and other MP/MF program loci, while restricting the effector program (Prdm1/Blimp1) and limiting Ahr expression; Bcl11b acts upstream of Tcf1 and Blimp1 in the tissue residency program.","method":"Post-activation conditional Bcl11b KO in CD8+ T cells; ATAC-seq; ChIP for histone marks; Listeria infection model; recall response assays","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with ATAC-seq and histone ChIP defining epigenetic mechanism, infection model with functional recall readout, genetic epistasis with Tcf1 and Blimp1","pmids":["37115913"],"is_preprint":false}],"current_model":"BCL11B (CTIP2) is a zinc finger transcription factor that functions as a context-dependent transcriptional repressor and activator: it homodimerizes via its N-terminal CCHC domain, recruits chromatin-modifying complexes including NuRD (via RbAp46/48 and MTA1/3), HDAC1/2, SUV39H1, and LSD1 to silence target genes through histone deacetylation and H3K9 methylation/heterochromatin formation, represses P-TEFb kinase activity by sequestering it in an inactive 7SK/HEXIM1 complex, and undergoes PKC-mediated phosphorylation at Ser2 that switches its cofactor preference from NuRD to P300, converting it from a repressor to an activator; in T cell development, BCL11B is activated by an asynchronous combinatorial mechanism involving TCF-1/GATA-3 locus poising, Notch-dependent stochastic permissivity, and Runx1-dependent amplitude control, after which it recruits mSWI/SNF with RUNX1 to poise effector chromatin landscapes, directly represses Id2 and Zbtb16 to block alternative innate fates, and interacts with GATA3 protein to co-regulate Th2 gene expression; in the nervous system, Bcl11b acts downstream of Fezf2 to specify subcortical projection neuron fate, directly regulates Desmoplakin in hippocampal neurogenesis, and controls mossy fiber-CA3 synapse function through a C1ql2/Nrxn3(25b+) signaling pathway."},"narrative":{"mechanistic_narrative":"BCL11B (CTIP2) is a C2H2 zinc finger transcription factor that acts as a context-dependent transcriptional repressor and activator governing cell-fate decisions across the immune, nervous, and epithelial systems [PMID:27376470, PMID:30374131]. Its repressive activity is executed through recruitment of chromatin-modifying machinery: BCL11B associates with the NuRD complex via direct interaction with RbAp46/RbAp48 to confer histone deacetylase activity at target promoters [PMID:16950772], recruits HDAC1/HDAC2 and cooperates with SUV39H1 to deposit H3K9 methylation and enable HP1-dependent heterochromatin formation [PMID:17245431, PMID:19581932], and partners with the LSD1 demethylase to silence transcription [PMID:22067449]. BCL11B homodimerizes through its N-terminal CCHC zinc finger, a domain necessary and sufficient for dimerization and required for its transcription-regulatory, cell-cycle-arrest, and anti-apoptotic functions [PMID:29203643]. Beyond chromatin silencing, BCL11B negatively regulates transcriptional elongation by associating with an inactive 7SK snRNP/HEXIM1 complex to repress P-TEFb/Cdk9 kinase activity, an inhibitory complex recruited to promoters by HMGA1 [PMID:23852730, PMID:24623795]. Its repressor-versus-activator output is switched by post-translational modification: PKC-mediated phosphorylation at Ser2 dampens NuRD (MTA1/MTA3/RbAp46) binding and instead recruits P300 to convert BCL11B into an activator at target promoters such as IL-2 and Id2 [PMID:27161321]. In T-lineage commitment, BCL11B is activated by an asynchronous combinatorial mechanism integrating TCF-1/GATA-3 locus poising, Notch-dependent stochastic permissivity, and Runx1 amplitude control [PMID:27376470], after which it collaborates with RUNX1 to maintain mSWI/SNF occupancy and poise effector chromatin landscapes [PMID:38632339], and represses Id2 and Zbtb16 to block alternative innate lymphoid, NK, and NKT fates [PMID:30374131]. This innate-fate-restricting role recurs across lymphoid lineages including ILC2s, Treg cells, NK cells, tissue-resident memory CD8+ T cells, and in suppressing NK-like reprogramming of T cells via NuRD [PMID:26231117, PMID:25964370, PMID:31457080, PMID:33712472, PMID:37115913, PMID:37737560]. In the nervous system, BCL11B acts downstream of Fezf2 to specify subcortical projection neuron identity [PMID:18678899], drives striatal medium spiny neuron differentiation and PKA signaling [PMID:18199763, PMID:31447328], directs hippocampal neurogenesis through its direct target Desmoplakin [PMID:22588081], and controls mossy fiber-CA3 synapse function via a C1ql2/Nrxn3(25b+) pathway [PMID:38358390]. BCL11B binding sites, motif preferences, partner complexes, and post-translational modifications are cell-type-specific, explaining how a single factor controls distinct gene programs in different lineages [PMID:31653691].","teleology":[{"year":2003,"claim":"Established BCL11B as an essential regulator of early thymocyte development, answering whether it had a non-redundant role in T-lineage differentiation and survival.","evidence":"Bcl11b knockout mice with flow cytometry and Tcrb PCR","pmids":["12717433"],"confidence":"High","gaps":["Did not define the molecular mechanism of Tcrb regulation","Direct target genes not identified"]},{"year":2003,"claim":"Showed BCL11B operates through heterochromatin association, linking it to HP1alpha and silencing of HIV-1 by sequestering Tat into inactive chromatin.","evidence":"Co-IP, confocal microscopy, and domain-mapping deletion mutants in microglial cells","pmids":["12692243"],"confidence":"High","gaps":["Cellular gene targets of HP1-bound BCL11B not addressed","Mechanism of recruitment to chromatin not defined"]},{"year":2006,"claim":"Defined the molecular basis of BCL11B repression by mapping a direct interaction with NuRD subunits RbAp46/48 that confers HDAC activity to BCL11B complexes.","evidence":"Co-IP, ChIP at p57KIP2, and HDAC activity assays in neuroblastoma cells","pmids":["16950772"],"confidence":"High","gaps":["Did not establish whether NuRD recruitment is universal across target genes","Other NuRD subunit contacts not mapped"]},{"year":2007,"claim":"Resolved the chromatin-silencing mechanism by showing BCL11B recruits HDAC1/2 and cooperates with SUV39H1 for H3K9 methylation and HP1-mediated heterochromatin.","evidence":"Reciprocal Co-IP, ChIP, and reporter assays at the HIV-1 promoter","pmids":["17245431"],"confidence":"High","gaps":["Order of HDAC versus methyltransferase recruitment unresolved","Generalization beyond HIV-1 promoter not tested here"]},{"year":2007,"claim":"Extended BCL11B function to positive selection of both T-cell lineages, tying its survival role to proximal TCR signaling competence.","evidence":"Conditional KO mice with calcium flux, ERK phosphorylation, and TCR transgene rescue","pmids":["17998389"],"confidence":"High","gaps":["Direct transcriptional targets controlling TCR signaling not identified","Link to chromatin machinery not made"]},{"year":2008,"claim":"Placed Bcl11b genetically downstream of Fezf2 in cortical subcortical projection neuron fate specification, defining a CNS developmental pathway.","evidence":"Fezf2 KO mice, in utero electroporation, axonal tracing, and double-mutant epistasis","pmids":["18678899"],"confidence":"High","gaps":["Direct Bcl11b target genes in this fate decision not defined","Cofactor requirements unknown"]},{"year":2008,"claim":"Identified Bcl11b as a master regulator of striatal medium spiny neuron differentiation and architecture.","evidence":"Ctip2 KO mice, immunohistochemistry, and striatal histology","pmids":["18199763"],"confidence":"High","gaps":["Whether downstream markers are direct targets not established","Mechanism of patch aggregation control unknown"]},{"year":2009,"claim":"Generalized the SUV39H1-cooperative silencing mechanism to the cell-cycle gene p21, linking BCL11B to proliferation control.","evidence":"ChIP, chaetocin inhibition, siRNA, and cell cycle analysis","pmids":["19581932"],"confidence":"High","gaps":["Direct BCL11B binding to p21 promoter versus indirect recruitment not fully separated"]},{"year":2012,"claim":"Defined Bcl11b as a direct transcriptional driver of hippocampal neurogenesis via its target Desmoplakin, established by rescue.","evidence":"Forebrain-specific KO, ChIP, Desmoplakin rescue, and behavioral testing","pmids":["22588081"],"confidence":"High","gaps":["Cofactors mediating Desmoplakin regulation not identified"]},{"year":2012,"claim":"Revealed BCL11B as a bidirectional context-dependent regulator in epithelial development, controlling FGF/TGFbeta/Shh networks and epidermal lipid metabolism.","evidence":"Tissue-specific conditional KO, ChIP, and lipidomics across incisor and epidermis","pmids":["22629441","23096701","23015591"],"confidence":"Medium","gaps":["Direct versus indirect target distinction incomplete for some networks","PTM-driven degradation (calcium, SUMO/ubiquitin) mechanistic detail limited to single lab"]},{"year":2013,"claim":"Discovered a non-chromatin repressive mechanism: BCL11B sequesters P-TEFb in an inactive 7SK/HEXIM1 complex to repress Cdk9 and elongation, with disease relevance in cardiac hypertrophy.","evidence":"Co-purification, Cdk9 kinase assay, ChIP at MYH7, and hypertrophic heart model","pmids":["23852730"],"confidence":"High","gaps":["How BCL11B is recruited to the 7SK snRNP initially not resolved here"]},{"year":2014,"claim":"Identified HMGA1 as the recruiting factor delivering the inactive BCL11B/P-TEFb complex to promoters, solving the recruitment question.","evidence":"ChIP and combinatorial siRNA knockdown of HMGA1 and CTIP2","pmids":["24623795"],"confidence":"Medium","gaps":["Direct HMGA1-BCL11B contact versus bridging not fully mapped","Single lab"]},{"year":2014,"claim":"Showed Ctip2 directly represses Unc5C in cortical neurons to control corticofugal axon projection via the Netrin1-Unc5C axis.","evidence":"Conditional KO, ChIP, axonal tracing, and Unc5C epistasis","pmids":["24739528"],"confidence":"Medium","gaps":["Single lab","Cofactor mediating Unc5C repression unknown"]},{"year":2016,"claim":"Defined how Bcl11b expression is itself switched on, revealing an asynchronous combinatorial logic of TCF-1/GATA-3 poising, Notch permissivity, and Runx1 amplitude control.","evidence":"Single-cell live imaging with knock-in reporter and genetic perturbations","pmids":["27376470"],"confidence":"High","gaps":["Molecular nature of the stochastic Notch step not resolved","How inputs converge at the locus mechanistically unclear"]},{"year":2016,"claim":"Established a PTM-driven repressor-to-activator switch: PKC phosphorylation at Ser2 trades NuRD binding for P300 recruitment at the same promoters.","evidence":"Endogenous MTA1/MTA3 Co-IP, phospho-specific antibodies, and ChIP in primary human CD4+ T cells","pmids":["27161321"],"confidence":"High","gaps":["Structural basis of how Ser2 phosphorylation alters cofactor affinity unknown","Whether other PTMs tune the switch not addressed here"]},{"year":2016,"claim":"Demonstrated that Bcl11b maintains innate lymphoid identity, being required for ILC2 development and suppression of the ILC3/RORgt program.","evidence":"Reporter and conditional KO mice, fetal liver chimeras, ChIP for Ahr, and infection models","pmids":["26231117","25964370"],"confidence":"High","gaps":["Cofactor complexes in ILC2s not defined in these studies","Direct versus indirect control of Gata3 not fully resolved"]},{"year":2018,"claim":"Mapped BCL11B homodimerization to the N-terminal CCHC zinc finger and showed it is required for transcriptional regulation, cell-cycle arrest, and apoptosis protection.","evidence":"FACS-FRET, AP-MS, and point mutagenesis with functional assays","pmids":["29203643"],"confidence":"High","gaps":["Structural model of the dimer interface not determined","Whether heterodimerization with paralogs occurs not tested"]},{"year":2018,"claim":"Defined the genome-wide cofactor landscape in pro-T cells, identifying RUNX1 as the most frequent collaborator and Id2/Zbtb16 as direct repressed targets controlling innate fate exclusion.","evidence":"AP-MS, ChIP-seq, RNA-seq, and stage-specific cofactor-deletion epistasis","pmids":["30374131"],"confidence":"High","gaps":["Mechanism dictating activation versus repression at individual RUNX1-shared sites unresolved"]},{"year":2018,"claim":"Showed Bcl11b physically binds GATA3 and co-regulates Th2 cytokine genes, maintaining chromatin states at the Th2 locus and restricting Runx3.","evidence":"Co-IP, ChIP-seq, ATAC-seq, and GATA3-dependence epistasis in Th2 cells","pmids":["29514917","29700302"],"confidence":"High","gaps":["Whether GATA3 interaction uses the same surface as NuRD not addressed"]},{"year":2019,"claim":"Demonstrated that Bcl11b restrains innate lineage programs in Treg cells through direct binding overlapping Foxp3 and chromatin accessibility control.","evidence":"Treg-specific KO, ChIP-seq, ATAC-seq, and autoimmunity phenotype","pmids":["31457080"],"confidence":"High","gaps":["Direct cooperativity with Foxp3 protein not biochemically tested here"]},{"year":2019,"claim":"Extended Bcl11b's binary-switch logic to olfactory receptor class choice and PKA signaling integration in human MSNs with Huntington's disease relevance.","evidence":"LOF/GOF mice and J-element analysis; transcriptomics and phospho-analysis of CTIP2-deficient human iPSC-MSNs","pmids":["31396576","31447328"],"confidence":"Medium","gaps":["Single lab for each","Direct target genes in PKA integration not fully mapped"]},{"year":2020,"claim":"Established the principle that Bcl11b uses cell-type-specific motifs, PTMs, and partner complexes to control entirely different gene sets in pro-T cells versus ILC2s.","evidence":"Comparative ChIP-seq, proteomics, and conditional cell-type-specific KO","pmids":["31653691"],"confidence":"High","gaps":["What dictates cell-type-specific motif selection mechanistically unknown"]},{"year":2023,"claim":"Linked BCL11B/NuRD repression of NK-cell fate in T cells to mitochondrial metabolism and acetyl-CoA-driven H3K27 acetylation, connecting metabolism to its epigenetic output.","evidence":"Co-IP, NuRD subunit and BCL11B deletion, metabolic profiling, and H3K27ac ChIP in human T cells","pmids":["37737560"],"confidence":"High","gaps":["Direct metabolic targets of repression not all identified"]},{"year":2024,"claim":"Defined a PU.1-to-BCL11B 'relay' maintaining mSWI/SNF and RUNX1 occupancy that poises the T effector chromatin landscape before TCR expression.","evidence":"ATAC-seq and ChIP-seq for BCL11B/RUNX1/PU.1/mSWI/SNF with stage-specific conditional KO","pmids":["38632339"],"confidence":"High","gaps":["Biochemical basis of the handoff between PU.1 and BCL11B not resolved"]},{"year":2024,"claim":"Connected Bcl11b to synaptic function by identifying C1ql2 as a direct target acting through Nrxn3(25b+) to control mossy fiber-CA3 LTP.","evidence":"ChIP, conditional KO, LTP electrophysiology, C1ql2-Nrxn3 Co-IP, and non-binding mutant rescue","pmids":["38358390"],"confidence":"High","gaps":["Cofactors mediating C1ql2 activation not identified"]},{"year":null,"claim":"How BCL11B integrates cell-type-specific PTMs, dimerization state, and partner availability to choose between repressive (NuRD/SUV39H1/P-TEFb) and activating (P300/mSWI/SNF) outputs at specific loci remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No structural model linking PTM state to cofactor choice","Rules governing cell-type-specific motif and complex selection unknown","Direct DNA-binding specificity at endogenous targets not biochemically defined across lineages"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[16,19,22,24,34]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[3,7,9,19,22]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[10,17]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[1,3]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,2,3,22,24]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[1,2]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[1,3,22,30,34]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[10,12,17,19]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,4,14,15,19,30,31,40]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[5,6,9,33,36]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[7,18,21]}],"complexes":["NuRD complex","inactive 7SK snRNP/HEXIM1/P-TEFb complex","mSWI/SNF"],"partners":["RBBP7","RBBP4","MTA1","SUV39H1","HEXIM1","HMGA1","RUNX1","GATA3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9C0K0","full_name":"B-cell lymphoma/leukemia 11B","aliases":["B-cell CLL/lymphoma 11B","COUP-TF-interacting protein 2","Radiation-induced tumor suppressor gene 1 protein","hRit1"],"length_aa":894,"mass_kda":95.5,"function":"Key regulator of both differentiation and survival of T-lymphocytes during thymocyte development in mammals. Essential in controlling the responsiveness of hematopoietic stem cells to chemotactic signals by modulating the expression of the receptors CCR7 and CCR9, which direct the movement of progenitor cells from the bone marrow to the thymus (PubMed:27959755). Is a regulator of IL2 promoter and enhances IL2 expression in activated CD4(+) T-lymphocytes (PubMed:16809611). Tumor-suppressor that represses transcription through direct, TFCOUP2-independent binding to a GC-rich response element (By similarity). May also function in the P53-signaling pathway (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9C0K0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BCL11B","classification":"Not Classified","n_dependent_lines":18,"n_total_lines":1208,"dependency_fraction":0.014900662251655629},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BCL11B","total_profiled":1310},"omim":[{"mim_id":"618092","title":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA","url":"https://www.omim.org/entry/618092"},{"mim_id":"617800","title":"MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19","url":"https://www.omim.org/entry/617800"},{"mim_id":"617237","title":"IMMUNODEFICIENCY 49, SEVERE COMBINED; IMD49","url":"https://www.omim.org/entry/617237"},{"mim_id":"607414","title":"FEZ FAMILY ZINC FINGER PROTEIN 2; FEZF2","url":"https://www.omim.org/entry/607414"},{"mim_id":"606990","title":"COATOMER PROTEIN COMPLEX, SUBUNIT BETA-2; COPB2","url":"https://www.omim.org/entry/606990"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Nucleoli fibrillar center","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":12.4},{"tissue":"lymphoid tissue","ntpm":34.1},{"tissue":"skin 1","ntpm":14.2}],"url":"https://www.proteinatlas.org/search/BCL11B"},"hgnc":{"alias_symbol":["CTIP-2","CTIP2","hRIT1-alpha","SMARCM2"],"prev_symbol":["ZNF856B"]},"alphafold":{"accession":"Q9C0K0","domains":[{"cath_id":"3.30.160.60","chopping":"426-477","consensus_level":"high","plddt":86.2194,"start":426,"end":477},{"cath_id":"3.30.160","chopping":"854-887","consensus_level":"medium","plddt":74.2174,"start":854,"end":887}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9C0K0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9C0K0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9C0K0-F1-predicted_aligned_error_v6.png","plddt_mean":50.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BCL11B","jax_strain_url":"https://www.jax.org/strain/search?query=BCL11B"},"sequence":{"accession":"Q9C0K0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9C0K0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9C0K0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9C0K0"}},"corpus_meta":[{"pmid":"12717433","id":"PMC_12717433","title":"Bcl11b is required for differentiation and survival of alphabeta T lymphocytes.","date":"2003","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12717433","citation_count":300,"is_preprint":false},{"pmid":"17245431","id":"PMC_17245431","title":"Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17245431","citation_count":297,"is_preprint":false},{"pmid":"18678899","id":"PMC_18678899","title":"The Fezf2-Ctip2 genetic pathway regulates the fate choice of subcortical projection neurons in the developing cerebral cortex.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18678899","citation_count":279,"is_preprint":false},{"pmid":"18199763","id":"PMC_18199763","title":"Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18199763","citation_count":264,"is_preprint":false},{"pmid":"34103329","id":"PMC_34103329","title":"Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia.","date":"2021","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/34103329","citation_count":159,"is_preprint":false},{"pmid":"26231117","id":"PMC_26231117","title":"Transcription Factor Bcl11b Controls Identity and Function of Mature Type 2 Innate Lymphoid Cells.","date":"2015","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/26231117","citation_count":146,"is_preprint":false},{"pmid":"25964370","id":"PMC_25964370","title":"Bcl11b is essential for group 2 innate lymphoid cell development.","date":"2015","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25964370","citation_count":139,"is_preprint":false},{"pmid":"15465497","id":"PMC_15465497","title":"CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis.","date":"2004","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/15465497","citation_count":132,"is_preprint":false},{"pmid":"17998389","id":"PMC_17998389","title":"BCL11B is required for positive selection and survival of double-positive thymocytes.","date":"2007","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17998389","citation_count":117,"is_preprint":false},{"pmid":"27376470","id":"PMC_27376470","title":"Asynchronous combinatorial action of four regulatory factors activates Bcl11b for T cell commitment.","date":"2016","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27376470","citation_count":114,"is_preprint":false},{"pmid":"23741008","id":"PMC_23741008","title":"A far downstream enhancer for murine Bcl11b controls its T-cell specific expression.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23741008","citation_count":105,"is_preprint":false},{"pmid":"12565905","id":"PMC_12565905","title":"Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12565905","citation_count":104,"is_preprint":false},{"pmid":"19581932","id":"PMC_19581932","title":"p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1.","date":"2009","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/19581932","citation_count":101,"is_preprint":false},{"pmid":"22588081","id":"PMC_22588081","title":"A dual function of Bcl11b/Ctip2 in hippocampal neurogenesis.","date":"2012","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22588081","citation_count":99,"is_preprint":false},{"pmid":"30374131","id":"PMC_30374131","title":"Bcl11b sets pro-T cell fate by site-specific cofactor recruitment and by repressing Id2 and Zbtb16.","date":"2018","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30374131","citation_count":97,"is_preprint":false},{"pmid":"15668700","id":"PMC_15668700","title":"Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.","date":"2005","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/15668700","citation_count":97,"is_preprint":false},{"pmid":"20969590","id":"PMC_20969590","title":"Critical roles of Bcl11b in T-cell development and maintenance of T-cell identity.","date":"2010","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/20969590","citation_count":94,"is_preprint":false},{"pmid":"28041896","id":"PMC_28041896","title":"A Quiescent Bcl11b High Stem Cell Population Is Required for Maintenance of the Mammary Gland.","date":"2016","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/28041896","citation_count":92,"is_preprint":false},{"pmid":"16950772","id":"PMC_16950772","title":"CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16950772","citation_count":86,"is_preprint":false},{"pmid":"25128552","id":"PMC_25128552","title":"The multifaceted roles of Bcl11b in thymic and peripheral T cells: impact on immune diseases.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25128552","citation_count":78,"is_preprint":false},{"pmid":"23852730","id":"PMC_23852730","title":"CTIP2 is a negative regulator of P-TEFb.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23852730","citation_count":75,"is_preprint":false},{"pmid":"33876209","id":"PMC_33876209","title":"14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.","date":"2021","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/33876209","citation_count":74,"is_preprint":false},{"pmid":"33712472","id":"PMC_33712472","title":"The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation.","date":"2021","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33712472","citation_count":73,"is_preprint":false},{"pmid":"22068335","id":"PMC_22068335","title":"Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium.","date":"2011","source":"Circulation. Cardiovascular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22068335","citation_count":73,"is_preprint":false},{"pmid":"28584128","id":"PMC_28584128","title":"Bcl11b and combinatorial resolution of cell fate in the T-cell gene regulatory network.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28584128","citation_count":72,"is_preprint":false},{"pmid":"23175820","id":"PMC_23175820","title":"The CB(1) cannabinoid receptor drives corticospinal motor neuron differentiation through the Ctip2/Satb2 transcriptional regulation axis.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23175820","citation_count":69,"is_preprint":false},{"pmid":"17173069","id":"PMC_17173069","title":"Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17173069","citation_count":68,"is_preprint":false},{"pmid":"22067449","id":"PMC_22067449","title":"LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing.","date":"2011","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/22067449","citation_count":67,"is_preprint":false},{"pmid":"12692243","id":"PMC_12692243","title":"Recruitment of Tat to heterochromatin protein HP1 via interaction with CTIP2 inhibits human immunodeficiency virus type 1 replication in microglial cells.","date":"2003","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/12692243","citation_count":65,"is_preprint":false},{"pmid":"28424591","id":"PMC_28424591","title":"Bcl11b-A Critical Neurodevelopmental Transcription Factor-Roles in Health and Disease.","date":"2017","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28424591","citation_count":60,"is_preprint":false},{"pmid":"24739528","id":"PMC_24739528","title":"Unc5C and DCC act downstream of Ctip2 and Satb2 and contribute to corpus callosum formation.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24739528","citation_count":59,"is_preprint":false},{"pmid":"31653691","id":"PMC_31653691","title":"Cell type-specific actions of Bcl11b in early T-lineage and group 2 innate lymphoid cells.","date":"2020","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31653691","citation_count":57,"is_preprint":false},{"pmid":"22450536","id":"PMC_22450536","title":"Role of the transcription factor Bcl11b in development and lymphomagenesis.","date":"2012","source":"Proceedings of the Japan Academy. Series B, Physical and biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22450536","citation_count":56,"is_preprint":false},{"pmid":"21752992","id":"PMC_21752992","title":"Bcl11b/Ctip2 controls the differentiation of vomeronasal sensory neurons in mice.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21752992","citation_count":54,"is_preprint":false},{"pmid":"19251658","id":"PMC_19251658","title":"Ctip2/Bcl11b controls ameloblast formation during mammalian odontogenesis.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19251658","citation_count":54,"is_preprint":false},{"pmid":"28232744","id":"PMC_28232744","title":"The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation.","date":"2017","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/28232744","citation_count":52,"is_preprint":false},{"pmid":"22383956","id":"PMC_22383956","title":"Delayed cutaneous wound healing and aberrant expression of hair follicle stem cell markers in mice selectively lacking Ctip2 in epidermis.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22383956","citation_count":51,"is_preprint":false},{"pmid":"28951542","id":"PMC_28951542","title":"Priming of lineage-specifying genes by Bcl11b is required for lineage choice in post-selection thymocytes.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28951542","citation_count":50,"is_preprint":false},{"pmid":"24623795","id":"PMC_24623795","title":"HMGA1 recruits CTIP2-repressed P-TEFb to the HIV-1 and cellular target promoters.","date":"2014","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/24623795","citation_count":47,"is_preprint":false},{"pmid":"17306224","id":"PMC_17306224","title":"Haploinsufficiency of Bcl11b for suppression of lymphomagenesis and thymocyte development.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17306224","citation_count":47,"is_preprint":false},{"pmid":"29514917","id":"PMC_29514917","title":"Bcl11b, a novel GATA3-interacting protein, suppresses Th1 while limiting Th2 cell differentiation.","date":"2018","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29514917","citation_count":46,"is_preprint":false},{"pmid":"12661009","id":"PMC_12661009","title":"Activation of HOX11L2 by juxtaposition with 3'-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2).","date":"2003","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12661009","citation_count":46,"is_preprint":false},{"pmid":"21060114","id":"PMC_21060114","title":"The corticofugal neuron-associated genes ROBO1, SRGAP1, and CTIP2 exhibit an anterior to posterior gradient of expression in early fetal human neocortex development.","date":"2010","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/21060114","citation_count":44,"is_preprint":false},{"pmid":"35594339","id":"PMC_35594339","title":"Single-cell deletion analyses show control of pro-T cell developmental speed and pathways by Tcf7, Spi1, Gata3, Bcl11a, Erg, and Bcl11b.","date":"2022","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35594339","citation_count":42,"is_preprint":false},{"pmid":"28794504","id":"PMC_28794504","title":"Promoter hypermethylation of BCL11B gene correlates with downregulation of gene transcription in ankylosing spondylitis patients.","date":"2017","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/28794504","citation_count":42,"is_preprint":false},{"pmid":"23527175","id":"PMC_23527175","title":"BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23527175","citation_count":38,"is_preprint":false},{"pmid":"23284675","id":"PMC_23284675","title":"Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23284675","citation_count":36,"is_preprint":false},{"pmid":"29700302","id":"PMC_29700302","title":"Bcl11b is essential for licensing Th2 differentiation during helminth infection and allergic asthma.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29700302","citation_count":33,"is_preprint":false},{"pmid":"32255245","id":"PMC_32255245","title":"Distinct Notch1 and BCL11B requirements mediate human γδ/αβ T cell development.","date":"2020","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/32255245","citation_count":32,"is_preprint":false},{"pmid":"26915960","id":"PMC_26915960","title":"Structure-function integrity of the adult hippocampus depends on the transcription factor Bcl11b/Ctip2.","date":"2016","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/26915960","citation_count":32,"is_preprint":false},{"pmid":"23015591","id":"PMC_23015591","title":"Ctip2 is a dynamic regulator of epidermal proliferation and differentiation by integrating EGFR and Notch signaling.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/23015591","citation_count":32,"is_preprint":false},{"pmid":"31396576","id":"PMC_31396576","title":"Bcl11b controls odorant receptor class choice in mice.","date":"2019","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/31396576","citation_count":31,"is_preprint":false},{"pmid":"17631058","id":"PMC_17631058","title":"Expression of COUP-TF-interacting protein 2 (CTIP2) in mouse skin during development and in adulthood.","date":"2007","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/17631058","citation_count":31,"is_preprint":false},{"pmid":"21756541","id":"PMC_21756541","title":"Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA.","date":"2011","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/21756541","citation_count":29,"is_preprint":false},{"pmid":"31457080","id":"PMC_31457080","title":"Bcl11b prevents fatal autoimmunity by promoting Treg cell program and constraining innate lineages in Treg cells.","date":"2019","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/31457080","citation_count":29,"is_preprint":false},{"pmid":"27161321","id":"PMC_27161321","title":"Protein Kinase C-Mediated Phosphorylation of BCL11B at Serine 2 Negatively Regulates Its Interaction with NuRD Complexes during CD4+ T-Cell Activation.","date":"2016","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27161321","citation_count":29,"is_preprint":false},{"pmid":"31511615","id":"PMC_31511615","title":"HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31511615","citation_count":28,"is_preprint":false},{"pmid":"29203643","id":"PMC_29203643","title":"The N-Terminal CCHC Zinc Finger Motif Mediates Homodimerization of Transcription Factor BCL11B.","date":"2018","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29203643","citation_count":28,"is_preprint":false},{"pmid":"33663588","id":"PMC_33663588","title":"Inhibition of BCL11B induces downregulation of PTK7 and results in growth retardation and apoptosis in T-cell acute lymphoblastic leukemia.","date":"2021","source":"Biomarker research","url":"https://pubmed.ncbi.nlm.nih.gov/33663588","citation_count":28,"is_preprint":false},{"pmid":"19399189","id":"PMC_19399189","title":"CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19399189","citation_count":27,"is_preprint":false},{"pmid":"34963132","id":"PMC_34963132","title":"Transcription factors Bcl11a and Bcl11b are required for the production and differentiation of cortical projection neurons.","date":"2022","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/34963132","citation_count":27,"is_preprint":false},{"pmid":"26698402","id":"PMC_26698402","title":"BCL11B/CTIP2 is highly expressed in GABAergic interneurons of the mouse somatosensory cortex.","date":"2015","source":"Journal of chemical neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/26698402","citation_count":26,"is_preprint":false},{"pmid":"27725726","id":"PMC_27725726","title":"HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27725726","citation_count":26,"is_preprint":false},{"pmid":"36075976","id":"PMC_36075976","title":"Comparative roadmaps of reprogramming and oncogenic transformation identify Bcl11b and Atoh8 as broad regulators of cellular plasticity.","date":"2022","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36075976","citation_count":26,"is_preprint":false},{"pmid":"21080944","id":"PMC_21080944","title":"Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia.","date":"2010","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/21080944","citation_count":26,"is_preprint":false},{"pmid":"22629441","id":"PMC_22629441","title":"BCL11B regulates epithelial proliferation and asymmetric development of the mouse mandibular incisor.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22629441","citation_count":26,"is_preprint":false},{"pmid":"33194885","id":"PMC_33194885","title":"Mutant BCL11B in a Patient With a Neurodevelopmental Disorder and T-Cell Abnormalities.","date":"2020","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/33194885","citation_count":25,"is_preprint":false},{"pmid":"28652615","id":"PMC_28652615","title":"Gga-miR-219b targeting BCL11B suppresses proliferation, migration and invasion of Marek's disease tumor cell MSB1.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28652615","citation_count":25,"is_preprint":false},{"pmid":"20824091","id":"PMC_20824091","title":"Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20824091","citation_count":25,"is_preprint":false},{"pmid":"23096701","id":"PMC_23096701","title":"Transcription factor Ctip2 controls epidermal lipid metabolism and regulates expression of genes involved in sphingolipid biosynthesis during skin development.","date":"2012","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/23096701","citation_count":24,"is_preprint":false},{"pmid":"33936112","id":"PMC_33936112","title":"Epigenetic Dynamics in the Function of T-Lineage Regulatory Factor Bcl11b.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33936112","citation_count":24,"is_preprint":false},{"pmid":"31447328","id":"PMC_31447328","title":"CTIP2-Regulated Reduction in PKA-Dependent DARPP32 Phosphorylation in Human Medium Spiny Neurons: Implications for Huntington Disease.","date":"2019","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31447328","citation_count":23,"is_preprint":false},{"pmid":"33376550","id":"PMC_33376550","title":"miR-21-5p promotes cell proliferation by targeting BCL11B in Thp-1 cells.","date":"2020","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/33376550","citation_count":23,"is_preprint":false},{"pmid":"27330109","id":"PMC_27330109","title":"Transcription factor Bcl11b sustains iNKT1 and iNKT2 cell programs, restricts iNKT17 cell program, and governs iNKT cell survival.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27330109","citation_count":23,"is_preprint":false},{"pmid":"29749698","id":"PMC_29749698","title":"Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia.","date":"2018","source":"Asia-Pacific journal of clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29749698","citation_count":23,"is_preprint":false},{"pmid":"38632339","id":"PMC_38632339","title":"PU.1 and BCL11B sequentially cooperate with RUNX1 to anchor mSWI/SNF to poise the T cell effector landscape.","date":"2024","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38632339","citation_count":22,"is_preprint":false},{"pmid":"25023966","id":"PMC_25023966","title":"Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients.","date":"2014","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25023966","citation_count":22,"is_preprint":false},{"pmid":"25827435","id":"PMC_25827435","title":"Bcl11b SWI/SNF-complex subunit modulates intestinal adenoma and regeneration after γ-irradiation through Wnt/β-catenin pathway.","date":"2015","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/25827435","citation_count":21,"is_preprint":false},{"pmid":"23383087","id":"PMC_23383087","title":"Reduced level of the BCL11B protein is associated with adult T-cell leukemia/lymphoma.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23383087","citation_count":20,"is_preprint":false},{"pmid":"33363142","id":"PMC_33363142","title":"Bcl11b/Ctip2 in Skin, Tooth, and Craniofacial System.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33363142","citation_count":19,"is_preprint":false},{"pmid":"31479431","id":"PMC_31479431","title":"Chimeric antigen receptor-induced BCL11B suppression propagates NK-like cell development.","date":"2019","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/31479431","citation_count":19,"is_preprint":false},{"pmid":"26453795","id":"PMC_26453795","title":"BCL11B regulates sutural patency in the mouse craniofacial skeleton.","date":"2015","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26453795","citation_count":19,"is_preprint":false},{"pmid":"34865701","id":"PMC_34865701","title":"Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage.","date":"2021","source":"Best practice & research. Clinical haematology","url":"https://pubmed.ncbi.nlm.nih.gov/34865701","citation_count":19,"is_preprint":false},{"pmid":"27790219","id":"PMC_27790219","title":"Transcription Factor Bcl11b Controls Effector and Memory CD8 T cell Fate Decision and Function during Poxvirus Infection.","date":"2016","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27790219","citation_count":19,"is_preprint":false},{"pmid":"33093445","id":"PMC_33093445","title":"BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33093445","citation_count":18,"is_preprint":false},{"pmid":"32164354","id":"PMC_32164354","title":"High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing Sarcoma.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32164354","citation_count":18,"is_preprint":false},{"pmid":"30088373","id":"PMC_30088373","title":"Bcl11b Regulates IL-17 Through the TGF-β/Smad Pathway in HDM-Induced Asthma.","date":"2018","source":"Allergy, asthma & immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/30088373","citation_count":18,"is_preprint":false},{"pmid":"27577752","id":"PMC_27577752","title":"N-acetylcysteine attenuates lipopolysaccharide-induced impairment in lamination of Ctip2-and Tbr1- expressing cortical neurons in the developing rat fetal brain.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27577752","citation_count":18,"is_preprint":false},{"pmid":"23040356","id":"PMC_23040356","title":"BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients.","date":"2012","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/23040356","citation_count":17,"is_preprint":false},{"pmid":"27586877","id":"PMC_27586877","title":"Identification of BCL11B as a regulator of adipogenesis.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27586877","citation_count":17,"is_preprint":false},{"pmid":"22426257","id":"PMC_22426257","title":"The role of BCL11B in regulating the proliferation of human naive T cells.","date":"2012","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22426257","citation_count":17,"is_preprint":false},{"pmid":"25422283","id":"PMC_25422283","title":"Bcl11b prevents the intrathymic development of innate CD8 T cells in a cell intrinsic manner.","date":"2014","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25422283","citation_count":17,"is_preprint":false},{"pmid":"37737560","id":"PMC_37737560","title":"BCL11B and the NuRD complex cooperatively guard T-cell fate and inhibit OPA1-mediated mitochondrial fusion in T cells.","date":"2023","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/37737560","citation_count":16,"is_preprint":false},{"pmid":"37115913","id":"PMC_37115913","title":"Bcl11b sustains multipotency and restricts effector programs of intestinal-resident memory CD8+ T cells.","date":"2023","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37115913","citation_count":16,"is_preprint":false},{"pmid":"38358390","id":"PMC_38358390","title":"Regulation of hippocampal mossy fiber-CA3 synapse function by a Bcl11b/C1ql2/Nrxn3(25b+) pathway.","date":"2024","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/38358390","citation_count":16,"is_preprint":false},{"pmid":"24446520","id":"PMC_24446520","title":"TNF-α-dependent hematopoiesis following Bcl11b deletion in T cells restricts metastatic melanoma.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24446520","citation_count":16,"is_preprint":false},{"pmid":"28288848","id":"PMC_28288848","title":"BCL11B-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma.","date":"2017","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/28288848","citation_count":16,"is_preprint":false},{"pmid":"23682716","id":"PMC_23682716","title":"Aberrant expression of BCL11B in mycosis fungoides and its potential role in interferon-induced apoptosis.","date":"2013","source":"The Journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/23682716","citation_count":15,"is_preprint":false},{"pmid":"26563995","id":"PMC_26563995","title":"Bcl11b: A New Piece to the Complex Puzzle of Amyotrophic Lateral Sclerosis Neuropathogenesis?","date":"2015","source":"Neurotoxicity research","url":"https://pubmed.ncbi.nlm.nih.gov/26563995","citation_count":14,"is_preprint":false},{"pmid":"25511173","id":"PMC_25511173","title":"BCL11B expression in intramembranous osteogenesis during murine craniofacial suture development.","date":"2014","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/25511173","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47474,"output_tokens":10715,"usd":0.151573,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":21345,"output_tokens":6906,"usd":0.139687,"stage2_stop_reason":"end_turn"},"total_usd":0.29126,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"Bcl11b is required for V(beta) to D(beta) recombination and Tcrb mRNA expression in thymocytes; Bcl11b-deficient mice show a developmental block at the CD4-CD8 double-negative stage with absent pre-TCR complex on the cell surface and profound apoptosis, establishing Bcl11b as a key regulator of both differentiation and survival during thymocyte development.\",\n      \"method\": \"Bcl11b knockout mouse model; flow cytometry; PCR for Tcrb expression\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO mouse with specific developmental phenotype and molecular mechanism (absent Tcrb mRNA, failed V(D)J recombination), replicated by multiple subsequent labs\",\n      \"pmids\": [\"12717433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CTIP2 (BCL11B) recruits histone deacetylases HDAC1 and HDAC2 to promote local histone H3 deacetylation at the HIV-1 promoter, and associates with histone methyltransferase SUV39H1 to increase local H3K9 methylation, enabling HP1 protein recruitment and heterochromatin formation to silence HIV-1 transcription in microglial cells.\",\n      \"method\": \"Co-immunoprecipitation; chromatin immunoprecipitation (ChIP); reporter assays; confocal microscopy in microglial cells\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP and ChIP with multiple orthogonal methods; independently replicated concept in subsequent papers\",\n      \"pmids\": [\"17245431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CTIP2 colocalizes and physically associates with heterochromatin protein HP1alpha, and forms a three-protein complex with HIV-1 Tat via two distinct CTIP2 domains (residues 145-434 for Tat binding, 717-813 for HP1 binding), recruiting Tat into inactive chromatin regions and inhibiting Tat-mediated transactivation of HIV-1 in microglial cells.\",\n      \"method\": \"Co-immunoprecipitation; confocal microscopy; deletion mutant analysis; HIV-1 replication assays\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, domain mapping with deletion mutants, and functional HIV-1 replication readout in single study\",\n      \"pmids\": [\"12692243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CTIP2 associates with the NuRD complex through direct interaction with RbAp46 and RbAp48 subunits, confers histone deacetylase activity to CTIP2 complexes, and co-occupies the p57KIP2 promoter with NuRD components to repress p57KIP2 transcription in neuroblastoma cells.\",\n      \"method\": \"Co-immunoprecipitation; chromatin immunoprecipitation (ChIP); HDAC activity assays; reporter assays in SK-N-MC cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct protein interaction mapped (RbAp46/48), ChIP at endogenous target gene, HDAC activity assay; multiple orthogonal methods in single study\",\n      \"pmids\": [\"16950772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BCL11B is required for positive selection of both CD4 and CD8 T cell lineages in double-positive thymocytes; BCL11B-deficient DP thymocytes display impaired proximal TCR signaling, attenuated ERK phosphorylation and calcium flux, and increased spontaneous apoptosis associated with elevated cleaved caspase-3 and altered pro-apoptotic/pro-survival factor balance.\",\n      \"method\": \"Conditional BCL11B knockout mice; flow cytometry; calcium flux assays; ERK phosphorylation assays; TCR transgene rescue experiments\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal functional assays in KO model with defined cellular and molecular phenotypes; TCR transgene rescue experiment provides epistasis\",\n      \"pmids\": [\"17998389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Ctip2 is a major downstream effector of Fezf2 in specifying subcortical projection neuron fate in the cerebral cortex; ectopic Ctip2 expression redirects callosal projection neurons to project subcortically, and Ctip2 can rescue the axonal phenotype of Fezf2 mutants, placing Ctip2 genetically downstream of Fezf2 in this pathway.\",\n      \"method\": \"Fezf2 knockout mice; in utero electroporation; axonal tracing; epistasis analysis with double mutants\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis via double mutant and rescue, axonal tracing; replicated by subsequent independent studies\",\n      \"pmids\": [\"18678899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Ctip2 is required for differentiation of striatal medium spiny neurons (MSN); in its absence, MSN markers including DARPP-32, FOXP1, Chrm4, and Plexin-D1 are dramatically reduced, MSN fail to aggregate into patches, and dopaminergic innervation is abnormal, establishing Ctip2 as a critical regulator of MSN differentiation and striatal architecture.\",\n      \"method\": \"Ctip2 knockout mice; immunohistochemistry; gene expression analysis; histological analysis of striatal organization\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with specific molecular and cellular phenotype; multiple downstream target genes identified; replicated concept in subsequent work\",\n      \"pmids\": [\"18199763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CTIP2 silences the p21(WAF1) gene promoter by recruiting histone deacetylases and cooperating with SUV39H1 histone methyltransferase; CTIP2 and SUV39H1 co-occupy the silenced p21 promoter and cooperatively inhibit p21 transcription through histone H3K9 trimethylation, and CTIP2 abolishes Vpr-mediated stimulation of p21.\",\n      \"method\": \"ChIP; pharmacological inhibition with chaetocin (SUV39H1 inhibitor); reporter assays; siRNA knockdown; cell cycle analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP at endogenous promoter, pharmacological inhibitor rescue, and functional cell cycle readout; multiple orthogonal methods\",\n      \"pmids\": [\"19581932\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"LSD1 histone demethylase cooperates with CTIP2 to repress HIV-1 transcription in a synergistic manner; LSD1 recruitment to the HIV-1 proximal promoter is associated with both H3K4me3 and H3K9me3 epigenetic marks.\",\n      \"method\": \"ChIP; siRNA knockdown of LSD1; reporter assays; viral expression assays in microglial cells\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — ChIP and siRNA in single study; synergy shown but direct interaction of CTIP2-LSD1 not fully established by Co-IP\",\n      \"pmids\": [\"22067449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Bcl11b/Ctip2 plays a dual role in hippocampal neurogenesis: it controls feedback regulation of the progenitor cell compartment and regulates granule cell differentiation. Desmoplakin is identified as a direct transcriptional target of Bcl11b, and re-expression of Desmoplakin in Bcl11b mutants rescues impaired neurogenesis, placing Bcl11b upstream of Desmoplakin in hippocampal development.\",\n      \"method\": \"Forebrain-specific Bcl11b knockout mice; ChIP for direct target identification; Desmoplakin rescue experiment; behavioral testing (spatial learning)\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct target gene identified by ChIP, genetic rescue experiment establishing epistasis, behavioral phenotype readout\",\n      \"pmids\": [\"22588081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CTIP2 is a negative regulator of P-TEFb activity; CTIP2 copurifies and interacts with an inactive P-TEFb complex containing 7SK snRNA and HEXIM1, associating directly with HEXIM1 and via the loop 2 of 7SK snRNA with P-TEFb, and significantly represses Cdk9 kinase activity. In hypertrophic cardiomyopathic mouse hearts, the inactive P-TEFb/CTIP2 complex associates with the MYH7 gene promoter to repress its activity.\",\n      \"method\": \"Co-purification; Co-immunoprecipitation; Cdk9 kinase activity assay; ChIP at MYH7 promoter; RNA-seq; siRNA knockdown\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro kinase assay + Co-IP of endogenous complex + ChIP at target promoter + disease model; multiple orthogonal methods\",\n      \"pmids\": [\"23852730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BCL11B acts as a transcriptional repressor in Ewing sarcoma and contributes to the EWS/FLI repressed gene signature; its repressive activity is mediated through the NuRD co-repressor complex. Re-expression of SPRY1, a repressed BCL11B target, limits transformation in Ewing sarcoma cells.\",\n      \"method\": \"siRNA knockdown; gene expression profiling; reporter assays; Co-immunoprecipitation for NuRD complex association\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for NuRD association, functional rescue with SPRY1 re-expression, KD with transformation phenotype; single lab\",\n      \"pmids\": [\"23527175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HMGA1 recruits the CTIP2-repressed inactive P-TEFb/7SK snRNP complex to cellular gene promoters and the HIV-1 promoter; HMGA1 knockdown reduces ChIP signals for CTIP2, 7SK, and P-TEFb at target promoters, revealing HMGA1 as the recruiting mechanism for the inactive P-TEFb complex.\",\n      \"method\": \"ChIP; siRNA knockdown of HMGA1 and CTIP2; reporter assays for HIV-1 and cellular promoters\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and combinatorial knockdown showing recruitment dependency; single lab, two orthogonal methods\",\n      \"pmids\": [\"24623795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Unc5C expression is under direct negative regulation by Ctip2 in cortical neurons; Ctip2 directly represses Unc5C, and the Netrin1-Unc5C interaction downstream of Ctip2 controls corticofugal axon projections.\",\n      \"method\": \"Conditional knockout mice; ChIP (direct regulation); axonal tracing; epistasis analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for direct target, genetic epistasis with Unc5C and Ctip2 mutants; single lab\",\n      \"pmids\": [\"24739528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Bcl11b acts directly upstream of Gfi1 to maintain its expression in mature ILC2s, and independently represses expression of the ILC3 transcription factor Ahr; Bcl11b-deficient ILC2s downregulate Gata3 and downstream IL-33 receptor, and upregulate Rorc and ILC3 genes, demonstrating a dual role in maintaining ILC2 identity and suppressing ILC3 programming.\",\n      \"method\": \"Conditional Bcl11b knockout mice; gene expression analysis; flow cytometry; functional cytokine production assays; ChIP for direct Ahr repression\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with defined target genes (Gfi1, Ahr), ChIP for direct binding, functional cytokine output readout; replicated in parallel independent study (PMID 25964370)\",\n      \"pmids\": [\"26231117\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Bcl11b is wholly required for ILC2 development; in vivo deletion of Bcl11b abolishes ILC2 generation with concomitant expansion of RORγt+ ILC3 population, suggesting Bcl11b negatively regulates the ILC3 lineage.\",\n      \"method\": \"Bcl11b reporter mice; conditional tamoxifen-induced deletion; fetal liver chimera reconstitution; flow cytometry; Nippostrongylus brasiliensis infection model\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent in vivo deletion strategies (inducible and chimera); functional infection model; replicated by Califano et al. simultaneously\",\n      \"pmids\": [\"25964370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Bcl11b expression is activated through three distinct asynchronous mechanisms during T cell commitment: an early locus 'poising' function dependent on TCF-1 and GATA-3, a stochastic-permissivity function dependent on Notch signaling, and an amplitude-control function dependent on Runx1; these inputs act in a stage-specific manner to activate Bcl11b.\",\n      \"method\": \"Single-cell live imaging with Bcl11b knock-in fluorescent reporter mice; genetic perturbations of TCF-1, GATA-3, Notch, and Runx1; clonal analysis\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — single-cell resolution with knock-in reporter, multiple genetic perturbations establishing mechanistic hierarchy; multiple orthogonal approaches in single rigorous study\",\n      \"pmids\": [\"27376470\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Protein kinase C (PKC)-mediated phosphorylation of BCL11B at Serine 2 negatively regulates its interaction with NuRD complexes by dampening interaction with MTA1/MTA3 and RbAp46; upon T cell activation, phospho-Ser2 BCL11B still binds IL-2 and Id2 promoters but recruits P300 instead of MTA1 to activate transcription, defining a PTM-driven repressor-to-activator switch.\",\n      \"method\": \"Co-immunoprecipitation of endogenous MTA1/MTA3; phospho-specific antibodies; ChIP at IL-2 and Id2 promoters; in vivo activation of primary human CD4+ T cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — endogenous Co-IP with mapped PTM site, ChIP showing cofactor switch at target promoters, validated in primary human cells\",\n      \"pmids\": [\"27161321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Bcl11b promotes mammary epithelial stem cell quiescence; gain- and loss-of-function studies show that Bcl11b induces cells to enter G0, and loss of Bcl11b leads to Cdkn2a-dependent exhaustion of ductal epithelium and loss of regenerative capacity.\",\n      \"method\": \"Conditional knockout mice; transplantation assays; gain-of-function overexpression; cell cycle analysis (G0 determination); genetic interaction with Cdkn2a\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO and OE with cell cycle readout, genetic epistasis with Cdkn2a; single lab\",\n      \"pmids\": [\"28041896\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Bcl11b recruits distinct cofactors to selective target sites in pro-T cells; proteomics identified multiple Bcl11b-associated cofactors, Runx1 collaborates most frequently for both activation and repression, and Bcl11b directly represses Id2 and Zbtb16, which in turn control alternative innate lymphoid and NK/NKT cell programs.\",\n      \"method\": \"Proteomics (affinity purification-MS); ChIP-seq; stage-specific in vivo and in vitro deletions; RNA-seq; cofactor deletion epistasis\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — AP-MS for cofactor identification, ChIP-seq for genome-wide binding, genetic deletion of individual cofactors; multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"30374131\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Bcl11b binds GATA3 through protein-protein interaction, and they co-localize at Th2 cis-regulatory elements. The GATA3/Bcl11b complex limits Th2 gene expression (IL-4, IL-5, IL-13), and Bcl11b upregulation of these cytokines in Bcl11b-deficient cells is completely GATA3-dependent.\",\n      \"method\": \"Co-immunoprecipitation; ChIP-seq; RNA-seq; Bcl11b conditional KO in Th2 cells; GATA3-dependence genetic rescue\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct protein interaction (Co-IP), genome-wide co-binding (ChIP-seq), and genetic GATA3 epistasis; multiple orthogonal methods\",\n      \"pmids\": [\"29514917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BCL11B homodimerizes via its N-terminal CCHC zinc finger motif; this CCHC ZF is necessary and sufficient for dimer formation, and mutation of the CCHC ZF abolishes BCL11B transcription-regulatory activity, its ability to induce cell cycle arrest, and its protection against DNA-damage-driven apoptosis.\",\n      \"method\": \"FACS-FRET assay; affinity purification followed by mass spectrometry; deletion/point mutagenesis; cell cycle and apoptosis assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — domain mapped by mutagenesis + FRET + AP-MS; functional consequences of dimerization disruption assessed; multiple orthogonal methods in single study\",\n      \"pmids\": [\"29203643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Bcl11b is required for maintaining chromatin accessibility at Th2-cytokine promoters and locus-control regions, binds the Il4 HS IV silencer to reduce its accessibility, binds Gata3-intronic and downstream non-coding sites to sustain Gata3 expression, and binds upstream enhancers at the Runx3 locus to deactivate them, thereby restricting Runx3 expression in Th2 cells.\",\n      \"method\": \"ChIP-seq; ATAC-seq; conditional Bcl11b KO in mature T cells; helminth infection and allergic asthma models\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq and ATAC-seq providing mechanistic chromatin-level evidence; in vivo disease models; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"29700302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HIV-1 Vpr mediates proteasomal degradation of CTIP2 in microglial cells and CD4+ T cells via association with the Cul4A-DDB1-DCAF1 ubiquitin ligase complex; this Vpr-dependent depletion of CTIP2 at the latent HIV-1 promoter counteracts CTIP2-mediated viral gene silencing and reactivates HIV-1 expression.\",\n      \"method\": \"Co-immunoprecipitation with Cul4A-DDB1-DCAF1 complex; proteasome inhibitor rescue; ChIP at HIV-1 promoter; microglial HIV-1 latency model\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP defining the ubiquitin ligase complex, proteasome inhibitor rescue, and ChIP; single lab\",\n      \"pmids\": [\"31511615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Bcl11b binding to genomic regions shows distinct cell-type-specific motif preferences and occupies functionally different sites in pro-T cells versus ILC2s, controlling totally different sets of target genes. In pro-T cells, Bcl11b represses Id2 preventing innate fates; in ILC2s, Bcl11b co-expresses with Id2 and does not repress it. Additionally, Bcl11b bears cell-type-specific post-translational modifications and organizes different cell-type-specific protein complexes.\",\n      \"method\": \"ChIP-seq comparing pro-T cells and ILC2s; proteomics; conditional cell-type-specific KO; gene expression analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — comparative ChIP-seq across cell types, AP-MS proteomics for complex composition, conditional KO; multiple orthogonal methods\",\n      \"pmids\": [\"31653691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Ctip2 directly and positively regulates EGFR transcription in proliferating keratinocytes and Notch1 transcription in differentiating keratinocytes, integrating proliferation/differentiation switching; EGFR activation downregulates Ctip2 at the transcript level, while high calcium signaling triggers SUMOylation, ubiquitination, and proteasomal degradation of Ctip2 protein.\",\n      \"method\": \"ChIP at EGFR and Notch1 promoters; reporter assays; calcium treatment; SUMOylation/ubiquitination assays; proteasome inhibitor experiments\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP at endogenous promoters plus PTM characterization; single lab with multiple methods\",\n      \"pmids\": [\"23015591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Bcl11b regulates Wnt/β-catenin target gene expression; introduction of BCL11B in human cell lines downregulated transcription of β-catenin target genes, and Bcl11b attenuation in intestinal Lgr5+ crypt base columnar cells increased expression of β-catenin targets c-Myc and cyclin D1, linking BCL11B to intestinal tumorigenesis suppression.\",\n      \"method\": \"BCL11B overexpression in human cell lines; luciferase reporter assays for β-catenin targets; Lgr5-specific conditional KO mice; Apc(min/+) tumor model\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay and conditional KO with pathway-specific readout; single lab\",\n      \"pmids\": [\"25827435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HIC1 physically interacts with both Bcl11b/CTIP2 and HMGA1 to co-regulate HIV-1 gene expression; HIC1 represses Tat-dependent HIV-1 transcription, this repression is linked to HIC1 K314 acetylation status and SIRT1 deacetylase activity, and HIC1 repression of Tat function occurs in a TAR-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation; reporter assays; siRNA knockdown; acetylation assays; SIRT1 inhibitor treatment\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for protein interactions, reporter assays, PTM (acetylation) dependency; single lab\",\n      \"pmids\": [\"27725726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Bcl11b is required for BCL11B-dependent repression of Thpok prior to the pre-selection stage of thymocyte development; this initial Thpok repression is independent of the known Thpok silencer and requires the last zinc-finger motif of Bcl11b, which is dispensable for T-lineage commitment, thus mechanistically separating priming of lineage-specifying genes from commitment.\",\n      \"method\": \"Conditional Bcl11b KO mice; zinc-finger domain deletion mutants; gene expression analysis of Thpok and Runx3; lineage scrambling analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain-specific mutant analysis separating functions, KO with specific molecular readout; single lab\",\n      \"pmids\": [\"28951542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Bcl11b controls odorant receptor class choice in olfactory sensory neurons; loss of Bcl11b causes neurons to adopt class I OR fate by default, while gain-of-function shows Bcl11b dictates class II OR choice by suppressing the activity of the J-element, a class I-OR enhancer, revealing a binary transcriptional switch mechanism.\",\n      \"method\": \"Conditional Bcl11b KO and gain-of-function mice; in situ hybridization for OR class expression; behavioral olfaction assays\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — both LOF and GOF genetic experiments establishing regulatory mechanism; single lab\",\n      \"pmids\": [\"31396576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Bcl11b directly binds genomic regulatory regions of Treg program genes, overlapping with Foxp3 binding, and controls their chromatin accessibility; Bcl11b-deficient Treg cells show decreased expression of essential Treg program genes and gain myeloid and NK cell programs, demonstrating Bcl11b restrains innate lineage programs in Treg cells.\",\n      \"method\": \"Treg-specific conditional KO mice; ChIP-seq; ATAC-seq; gene expression analysis; autoimmunity phenotypic assay\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq and ATAC-seq in KO Treg cells, comparison with Foxp3 binding, fatal autoimmunity phenotype; multiple orthogonal methods\",\n      \"pmids\": [\"31457080\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BCL11B regulates NK cell differentiation; Bcl11b represses RUNX2 in canonical NK cells and ZBTB16 in adaptive NK cells; ectopic Bcl11b expression drives NK cell differentiation, and Bcl11b is required for adaptive NK cell responses in a murine cytomegalovirus model.\",\n      \"method\": \"Transcriptomics and epigenomics of seven human NK cell populations; ectopic Bcl11b expression; BCL11B-mutated patient analysis; MCMV infection model\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ectopic expression, patient mutation validation, and infection model; multi-method single study\",\n      \"pmids\": [\"33712472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BCL11B and the NuRD complex physically associate and cooperatively repress NK-cell fate in T cells; deletion of NuRD subunits (MTA2, MBD2, CHD4) or BCL11B reprograms T cells into NK-like cells (ITNKs) that upregulate OPA1, exhibit elongated mitochondria with augmented OXPHOS, and elevated acetyl-CoA that drives H3K27 acetylation at specific targets.\",\n      \"method\": \"Co-immunoprecipitation of BCL11B with NuRD; genetic deletion of NuRD subunits and BCL11B in human T cells; metabolic profiling (OXPHOS); ChIP for H3K27ac; functional antitumor assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP of endogenous complex, multiple component deletions, metabolic mechanistic link to epigenetics via acetyl-CoA/H3K27ac; multiple orthogonal methods\",\n      \"pmids\": [\"37737560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Bcl11b directly regulates C1ql2, a synaptic organizer that controls synaptic vesicle recruitment and LTP at mossy fiber-CA3 synapses; C1ql2 exerts its function through direct interaction with the specific splice variant Nrxn3(25b+), and interruption of C1ql2-Nrxn3(25b+) interaction or deletion of Nrxn3 in dentate gyrus granule neurons recapitulates Bcl11b and C1ql2 mutant synaptic phenotypes.\",\n      \"method\": \"ChIP for direct Bcl11b target; conditional KO mice; electrophysiology (LTP at mossy fiber-CA3); Co-IP of C1ql2-Nrxn3(25b+); non-binding C1ql2 mutant rescue; synaptic vesicle analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct target identified by ChIP, interaction mapped by Co-IP with non-binding mutant, in vivo LTP assays, genetic rescue; multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"38358390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BCL11B succeeds PU.1 in a 'relay' mechanism to maintain mSWI/SNF chromatin remodeling complex occupancy together with RUNX1 at T effector loci after PU.1 silencing during lineage commitment, thereby poising the T cell effector chromatin landscape before TCR expression.\",\n      \"method\": \"ATAC-seq; ChIP-seq for BCL11B, RUNX1, PU.1, mSWI/SNF components; conditional KO at defined developmental stages; chromatin accessibility profiling\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq and ATAC-seq defining sequential occupancy mechanism, conditional KO validation; single rigorous study with multiple orthogonal genomic methods\",\n      \"pmids\": [\"38632339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CTIP2 governs PKA signaling in human medium spiny neurons; transcriptomic analysis of CTIP2-deficient MSNs identifies CTIP2 target genes at the heart of cAMP-Ca2+ signal integration, and CTIP2 deficiency causes substantial reduction in phosphorylation of DARPP32 and GLUR1, two PKA targets. This CTIP2-dependent dysregulation is shared by Huntington's disease hPSC-derived MSNs and HD mouse model striatal tissues.\",\n      \"method\": \"Transcriptomics of CTIP2-deficient human iPSC-derived MSNs; phosphorylation analysis of DARPP32 and GLUR1; HD mouse model validation\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO with specific molecular readout (phosphorylation), validated in disease model; single lab with two orthogonal approaches\",\n      \"pmids\": [\"31447328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BCL11B regulates FGF, TGFβ superfamily, Sprouty, and Sonic hedgehog pathway gene networks to control epithelial proliferation and developmental asymmetry of the mouse incisor; BCL11B is necessary for proliferation of the labial epithelium and suppresses epithelial proliferation on the lingual side, establishing bidirectional context-dependent transcriptional control.\",\n      \"method\": \"Bcl11b conditional KO mice (incisor-specific); ChIP; gene expression analysis of FGF/TGFβ/Shh target genes\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for direct target binding, KO with specific molecular network characterization; single lab\",\n      \"pmids\": [\"22629441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Bcl11b-deficient craniofacial skeleton shows increased proliferation of osteoprogenitors, premature osteoblast differentiation, and enhanced skull mineralization leading to craniosynostosis; ectopic expression of Fgfr2c and Runx2 is detected in affected sutures of Bcl11b-/- mice, suggesting BCL11B normally represses Fgfr2c in sutural mesenchyme to prevent the RUNX2-dependent osteogenic program.\",\n      \"method\": \"Bcl11b knockout mice; histology; immunohistochemistry for FGFR2c and RUNX2; gene expression analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — KO with specific molecular phenotype but direct regulation of Fgfr2c by BCL11B not confirmed by ChIP; single lab\",\n      \"pmids\": [\"26453795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BCL11B regulates adipogenesis by stimulating C/EBPβ transcriptional activity and suppressing the Wnt/β-catenin signaling pathway; BCL11B expression transiently increases during adipogenesis, BCL11B knockdown reduces adipogenic capacity in 3T3-L1 cells and MEFs, and BCL11B-/- MEFs show failure to suppress Wnt/β-catenin target genes during differentiation.\",\n      \"method\": \"BCL11B knockout MEFs; 3T3-L1 knockdown; luciferase reporter assays for C/EBPβ activity and β-catenin targets; gene expression analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO MEFs and knockdown cells with reporter assays defining pathway; single lab\",\n      \"pmids\": [\"27586877\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Ctip2 controls epidermal lipid metabolism; Ctip2-/- mice display altered ceramide and sphingomyelin composition, and Ctip2 is recruited to the promoter regions of genes involved in skin sphingolipid biosynthesis, suggesting direct transcriptional regulation of these genes.\",\n      \"method\": \"Ctip2 knockout mice; targeted lipidomics by mass spectrometry; ChIP at sphingolipid gene promoters\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for direct target genes combined with metabolomic phenotype in KO; single lab\",\n      \"pmids\": [\"23096701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Bcl11b sustains the multipotent/multifunctional transcriptional program of intestinal-resident memory CD8+ T cells by maintaining chromatin accessibility and activating histone marks at TCF7 and other MP/MF program loci, while restricting the effector program (Prdm1/Blimp1) and limiting Ahr expression; Bcl11b acts upstream of Tcf1 and Blimp1 in the tissue residency program.\",\n      \"method\": \"Post-activation conditional Bcl11b KO in CD8+ T cells; ATAC-seq; ChIP for histone marks; Listeria infection model; recall response assays\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with ATAC-seq and histone ChIP defining epigenetic mechanism, infection model with functional recall readout, genetic epistasis with Tcf1 and Blimp1\",\n      \"pmids\": [\"37115913\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BCL11B (CTIP2) is a zinc finger transcription factor that functions as a context-dependent transcriptional repressor and activator: it homodimerizes via its N-terminal CCHC domain, recruits chromatin-modifying complexes including NuRD (via RbAp46/48 and MTA1/3), HDAC1/2, SUV39H1, and LSD1 to silence target genes through histone deacetylation and H3K9 methylation/heterochromatin formation, represses P-TEFb kinase activity by sequestering it in an inactive 7SK/HEXIM1 complex, and undergoes PKC-mediated phosphorylation at Ser2 that switches its cofactor preference from NuRD to P300, converting it from a repressor to an activator; in T cell development, BCL11B is activated by an asynchronous combinatorial mechanism involving TCF-1/GATA-3 locus poising, Notch-dependent stochastic permissivity, and Runx1-dependent amplitude control, after which it recruits mSWI/SNF with RUNX1 to poise effector chromatin landscapes, directly represses Id2 and Zbtb16 to block alternative innate fates, and interacts with GATA3 protein to co-regulate Th2 gene expression; in the nervous system, Bcl11b acts downstream of Fezf2 to specify subcortical projection neuron fate, directly regulates Desmoplakin in hippocampal neurogenesis, and controls mossy fiber-CA3 synapse function through a C1ql2/Nrxn3(25b+) signaling pathway.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BCL11B (CTIP2) is a C2H2 zinc finger transcription factor that acts as a context-dependent transcriptional repressor and activator governing cell-fate decisions across the immune, nervous, and epithelial systems [#16, #19]. Its repressive activity is executed through recruitment of chromatin-modifying machinery: BCL11B associates with the NuRD complex via direct interaction with RbAp46/RbAp48 to confer histone deacetylase activity at target promoters [#3], recruits HDAC1/HDAC2 and cooperates with SUV39H1 to deposit H3K9 methylation and enable HP1-dependent heterochromatin formation [#1, #7], and partners with the LSD1 demethylase to silence transcription [#8]. BCL11B homodimerizes through its N-terminal CCHC zinc finger, a domain necessary and sufficient for dimerization and required for its transcription-regulatory, cell-cycle-arrest, and anti-apoptotic functions [#21]. Beyond chromatin silencing, BCL11B negatively regulates transcriptional elongation by associating with an inactive 7SK snRNP/HEXIM1 complex to repress P-TEFb/Cdk9 kinase activity, an inhibitory complex recruited to promoters by HMGA1 [#10, #12]. Its repressor-versus-activator output is switched by post-translational modification: PKC-mediated phosphorylation at Ser2 dampens NuRD (MTA1/MTA3/RbAp46) binding and instead recruits P300 to convert BCL11B into an activator at target promoters such as IL-2 and Id2 [#17]. In T-lineage commitment, BCL11B is activated by an asynchronous combinatorial mechanism integrating TCF-1/GATA-3 locus poising, Notch-dependent stochastic permissivity, and Runx1 amplitude control [#16], after which it collaborates with RUNX1 to maintain mSWI/SNF occupancy and poise effector chromatin landscapes [#34], and represses Id2 and Zbtb16 to block alternative innate lymphoid, NK, and NKT fates [#19]. This innate-fate-restricting role recurs across lymphoid lineages including ILC2s, Treg cells, NK cells, tissue-resident memory CD8+ T cells, and in suppressing NK-like reprogramming of T cells via NuRD [#14, #15, #30, #31, #40, #32]. In the nervous system, BCL11B acts downstream of Fezf2 to specify subcortical projection neuron identity [#5], drives striatal medium spiny neuron differentiation and PKA signaling [#6, #35], directs hippocampal neurogenesis through its direct target Desmoplakin [#9], and controls mossy fiber-CA3 synapse function via a C1ql2/Nrxn3(25b+) pathway [#33]. BCL11B binding sites, motif preferences, partner complexes, and post-translational modifications are cell-type-specific, explaining how a single factor controls distinct gene programs in different lineages [#24].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Established BCL11B as an essential regulator of early thymocyte development, answering whether it had a non-redundant role in T-lineage differentiation and survival.\",\n      \"evidence\": \"Bcl11b knockout mice with flow cytometry and Tcrb PCR\",\n      \"pmids\": [\"12717433\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the molecular mechanism of Tcrb regulation\", \"Direct target genes not identified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed BCL11B operates through heterochromatin association, linking it to HP1alpha and silencing of HIV-1 by sequestering Tat into inactive chromatin.\",\n      \"evidence\": \"Co-IP, confocal microscopy, and domain-mapping deletion mutants in microglial cells\",\n      \"pmids\": [\"12692243\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular gene targets of HP1-bound BCL11B not addressed\", \"Mechanism of recruitment to chromatin not defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined the molecular basis of BCL11B repression by mapping a direct interaction with NuRD subunits RbAp46/48 that confers HDAC activity to BCL11B complexes.\",\n      \"evidence\": \"Co-IP, ChIP at p57KIP2, and HDAC activity assays in neuroblastoma cells\",\n      \"pmids\": [\"16950772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish whether NuRD recruitment is universal across target genes\", \"Other NuRD subunit contacts not mapped\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolved the chromatin-silencing mechanism by showing BCL11B recruits HDAC1/2 and cooperates with SUV39H1 for H3K9 methylation and HP1-mediated heterochromatin.\",\n      \"evidence\": \"Reciprocal Co-IP, ChIP, and reporter assays at the HIV-1 promoter\",\n      \"pmids\": [\"17245431\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order of HDAC versus methyltransferase recruitment unresolved\", \"Generalization beyond HIV-1 promoter not tested here\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Extended BCL11B function to positive selection of both T-cell lineages, tying its survival role to proximal TCR signaling competence.\",\n      \"evidence\": \"Conditional KO mice with calcium flux, ERK phosphorylation, and TCR transgene rescue\",\n      \"pmids\": [\"17998389\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets controlling TCR signaling not identified\", \"Link to chromatin machinery not made\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Placed Bcl11b genetically downstream of Fezf2 in cortical subcortical projection neuron fate specification, defining a CNS developmental pathway.\",\n      \"evidence\": \"Fezf2 KO mice, in utero electroporation, axonal tracing, and double-mutant epistasis\",\n      \"pmids\": [\"18678899\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct Bcl11b target genes in this fate decision not defined\", \"Cofactor requirements unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified Bcl11b as a master regulator of striatal medium spiny neuron differentiation and architecture.\",\n      \"evidence\": \"Ctip2 KO mice, immunohistochemistry, and striatal histology\",\n      \"pmids\": [\"18199763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether downstream markers are direct targets not established\", \"Mechanism of patch aggregation control unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Generalized the SUV39H1-cooperative silencing mechanism to the cell-cycle gene p21, linking BCL11B to proliferation control.\",\n      \"evidence\": \"ChIP, chaetocin inhibition, siRNA, and cell cycle analysis\",\n      \"pmids\": [\"19581932\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct BCL11B binding to p21 promoter versus indirect recruitment not fully separated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined Bcl11b as a direct transcriptional driver of hippocampal neurogenesis via its target Desmoplakin, established by rescue.\",\n      \"evidence\": \"Forebrain-specific KO, ChIP, Desmoplakin rescue, and behavioral testing\",\n      \"pmids\": [\"22588081\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactors mediating Desmoplakin regulation not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Revealed BCL11B as a bidirectional context-dependent regulator in epithelial development, controlling FGF/TGFbeta/Shh networks and epidermal lipid metabolism.\",\n      \"evidence\": \"Tissue-specific conditional KO, ChIP, and lipidomics across incisor and epidermis\",\n      \"pmids\": [\"22629441\", \"23096701\", \"23015591\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct versus indirect target distinction incomplete for some networks\", \"PTM-driven degradation (calcium, SUMO/ubiquitin) mechanistic detail limited to single lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Discovered a non-chromatin repressive mechanism: BCL11B sequesters P-TEFb in an inactive 7SK/HEXIM1 complex to repress Cdk9 and elongation, with disease relevance in cardiac hypertrophy.\",\n      \"evidence\": \"Co-purification, Cdk9 kinase assay, ChIP at MYH7, and hypertrophic heart model\",\n      \"pmids\": [\"23852730\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How BCL11B is recruited to the 7SK snRNP initially not resolved here\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified HMGA1 as the recruiting factor delivering the inactive BCL11B/P-TEFb complex to promoters, solving the recruitment question.\",\n      \"evidence\": \"ChIP and combinatorial siRNA knockdown of HMGA1 and CTIP2\",\n      \"pmids\": [\"24623795\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct HMGA1-BCL11B contact versus bridging not fully mapped\", \"Single lab\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showed Ctip2 directly represses Unc5C in cortical neurons to control corticofugal axon projection via the Netrin1-Unc5C axis.\",\n      \"evidence\": \"Conditional KO, ChIP, axonal tracing, and Unc5C epistasis\",\n      \"pmids\": [\"24739528\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Cofactor mediating Unc5C repression unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined how Bcl11b expression is itself switched on, revealing an asynchronous combinatorial logic of TCF-1/GATA-3 poising, Notch permissivity, and Runx1 amplitude control.\",\n      \"evidence\": \"Single-cell live imaging with knock-in reporter and genetic perturbations\",\n      \"pmids\": [\"27376470\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular nature of the stochastic Notch step not resolved\", \"How inputs converge at the locus mechanistically unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established a PTM-driven repressor-to-activator switch: PKC phosphorylation at Ser2 trades NuRD binding for P300 recruitment at the same promoters.\",\n      \"evidence\": \"Endogenous MTA1/MTA3 Co-IP, phospho-specific antibodies, and ChIP in primary human CD4+ T cells\",\n      \"pmids\": [\"27161321\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of how Ser2 phosphorylation alters cofactor affinity unknown\", \"Whether other PTMs tune the switch not addressed here\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated that Bcl11b maintains innate lymphoid identity, being required for ILC2 development and suppression of the ILC3/RORgt program.\",\n      \"evidence\": \"Reporter and conditional KO mice, fetal liver chimeras, ChIP for Ahr, and infection models\",\n      \"pmids\": [\"26231117\", \"25964370\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactor complexes in ILC2s not defined in these studies\", \"Direct versus indirect control of Gata3 not fully resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Mapped BCL11B homodimerization to the N-terminal CCHC zinc finger and showed it is required for transcriptional regulation, cell-cycle arrest, and apoptosis protection.\",\n      \"evidence\": \"FACS-FRET, AP-MS, and point mutagenesis with functional assays\",\n      \"pmids\": [\"29203643\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural model of the dimer interface not determined\", \"Whether heterodimerization with paralogs occurs not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined the genome-wide cofactor landscape in pro-T cells, identifying RUNX1 as the most frequent collaborator and Id2/Zbtb16 as direct repressed targets controlling innate fate exclusion.\",\n      \"evidence\": \"AP-MS, ChIP-seq, RNA-seq, and stage-specific cofactor-deletion epistasis\",\n      \"pmids\": [\"30374131\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism dictating activation versus repression at individual RUNX1-shared sites unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed Bcl11b physically binds GATA3 and co-regulates Th2 cytokine genes, maintaining chromatin states at the Th2 locus and restricting Runx3.\",\n      \"evidence\": \"Co-IP, ChIP-seq, ATAC-seq, and GATA3-dependence epistasis in Th2 cells\",\n      \"pmids\": [\"29514917\", \"29700302\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GATA3 interaction uses the same surface as NuRD not addressed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated that Bcl11b restrains innate lineage programs in Treg cells through direct binding overlapping Foxp3 and chromatin accessibility control.\",\n      \"evidence\": \"Treg-specific KO, ChIP-seq, ATAC-seq, and autoimmunity phenotype\",\n      \"pmids\": [\"31457080\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct cooperativity with Foxp3 protein not biochemically tested here\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Extended Bcl11b's binary-switch logic to olfactory receptor class choice and PKA signaling integration in human MSNs with Huntington's disease relevance.\",\n      \"evidence\": \"LOF/GOF mice and J-element analysis; transcriptomics and phospho-analysis of CTIP2-deficient human iPSC-MSNs\",\n      \"pmids\": [\"31396576\", \"31447328\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab for each\", \"Direct target genes in PKA integration not fully mapped\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established the principle that Bcl11b uses cell-type-specific motifs, PTMs, and partner complexes to control entirely different gene sets in pro-T cells versus ILC2s.\",\n      \"evidence\": \"Comparative ChIP-seq, proteomics, and conditional cell-type-specific KO\",\n      \"pmids\": [\"31653691\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"What dictates cell-type-specific motif selection mechanistically unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Linked BCL11B/NuRD repression of NK-cell fate in T cells to mitochondrial metabolism and acetyl-CoA-driven H3K27 acetylation, connecting metabolism to its epigenetic output.\",\n      \"evidence\": \"Co-IP, NuRD subunit and BCL11B deletion, metabolic profiling, and H3K27ac ChIP in human T cells\",\n      \"pmids\": [\"37737560\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct metabolic targets of repression not all identified\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined a PU.1-to-BCL11B 'relay' maintaining mSWI/SNF and RUNX1 occupancy that poises the T effector chromatin landscape before TCR expression.\",\n      \"evidence\": \"ATAC-seq and ChIP-seq for BCL11B/RUNX1/PU.1/mSWI/SNF with stage-specific conditional KO\",\n      \"pmids\": [\"38632339\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biochemical basis of the handoff between PU.1 and BCL11B not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Connected Bcl11b to synaptic function by identifying C1ql2 as a direct target acting through Nrxn3(25b+) to control mossy fiber-CA3 LTP.\",\n      \"evidence\": \"ChIP, conditional KO, LTP electrophysiology, C1ql2-Nrxn3 Co-IP, and non-binding mutant rescue\",\n      \"pmids\": [\"38358390\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactors mediating C1ql2 activation not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How BCL11B integrates cell-type-specific PTMs, dimerization state, and partner availability to choose between repressive (NuRD/SUV39H1/P-TEFb) and activating (P300/mSWI/SNF) outputs at specific loci remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model linking PTM state to cofactor choice\", \"Rules governing cell-type-specific motif and complex selection unknown\", \"Direct DNA-binding specificity at endogenous targets not biochemically defined across lineages\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [16, 19, 22, 24, 34]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [3, 7, 9, 19, 22]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [10, 17]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [1, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 2, 3, 22, 24]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [1, 3, 22, 30, 34]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [10, 12, 17, 19]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 4, 14, 15, 19, 30, 31, 40]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [5, 6, 9, 33, 36]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [7, 18, 21]}\n    ],\n    \"complexes\": [\n      \"NuRD complex\",\n      \"inactive 7SK snRNP/HEXIM1/P-TEFb complex\",\n      \"mSWI/SNF\"\n    ],\n    \"partners\": [\n      \"RBBP7\",\n      \"RBBP4\",\n      \"MTA1\",\n      \"SUV39H1\",\n      \"HEXIM1\",\n      \"HMGA1\",\n      \"RUNX1\",\n      \"GATA3\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":9,"faith_pct":88.88888888888889}}